Human dander as a potential allergen source in atopic dogs :  allergen characterization and IgE-profiling by Resk, Nicole
I
N
O
E
S
K
C
L
 R
E
  
  
  
  
  
 
N
I
H
M
A
D
R
 I
 
A
N
E
T
P
U
A
 D
N
E
N
C
N
 A
O
YVVB LAUFERSWEILER VERLAG
édition scientifique
9 7 8 3 8 3 5 9 5 0 5 3 5
ISBN 3-8359-5053-3
VVB
édition scientifique
VVB LAUFERSWEILER VERLAG
VVB LAUFERSWEILER VERLAG
S TA U F E N B E R G R I N G  1 5
D - 3 5 3 9 6  G I E S S E N
Tel: 0641-5599888 Fax: -5599890
redak t ion@dok to rve r lag .de
w w w . d o k t o r v e r l a g . d e
HUMAN DANDER AS A POTENTIAL 
ALLERGEN SOURCE IN ATOPIC DOGS - 
ALLERGEN CHARACTERIZATION 
AND IgE-PROFILING
NICOLE RESK 
INAUGURAL-DISSERTATION
zur Erlangung des Grades eines 
Dr. med. vet. 
beim Fachbereich Veterinärmedizin
der Justus-Liebig-Universität Gießen
 
Das Werk ist in allen seinen Teilen urheberrechtlich geschützt. 
Jede Verwertung ist ohne schriftliche Zustimmung des Autors 
oder des Verlages unzulässig. Das gilt insbesondere für 
Vervielfältigungen, Übersetzungen, Mikroverfilmungen
 und die Einspeicherung in und Verarbeitung durch 
elektronische Systeme.
1. Auflage 2006
All rights reserved. No part of this publication may be
 reproduced, stored in a retrieval system, or transmitted, 
in any form or by any means, electronic, mechanical, 
photocopying, recording, or otherwise, without the prior 
written permission of the Author or the Publishers.
st1  Edition 2006
© 2006 by VVB LAUFERSWEILER VERLAG, Giessen
Printed in Germany 
VVB LAUFERSWEILER VERLAG
édition  scientifique
STAUFENBERGRING 15, D-35396 GIESSEN
Tel: 0641-5599888 Fax: 0641-5599890 
email: redaktion@doktorverlag.de
www.doktorverlag.de
  
Aus der Klinik für Kleintiere, Klinische Pathophysiologie und  
und Klinische Laboratoriumsdiagnostik der Justus-Liebig-Universität Gießen 
Betreuer: Prof. Dr. A. Moritz 
und dem Paul-Ehrlich-Institut (Bundesamt für Sera und Impfstoffe), Langen 
Betreuer: PD Dr. A. Hoffmann 
 
 
 
Human Dander as a Potential Allergen Source in Atopic Dogs –  
Allergen Characterization and IgE-Profiling 
 
 
 
INAUGURAL-DISSERTATION 
 zur Erlangung des Grades eines  
Dr.med.vet. 
beim Fachbereich Veterinärmedizin  
der Justus-Liebig-Universität Gießen 
__________________________________________________ 
 
 
eingereicht von 
 
 
Nicole Resk  
 
Tierärztin aus New Rochelle, N.Y., U.S.A.  
 
 
 
Gießen 2006 
  
Mit Genehmigung des Fachbereiches Veterinärmedizin  
der Justus-Liebig-Universität Gießen 
 
 
 
 
 
 
Dekan: Prof. Dr. M. Reinacher 
 
Gutachter:  
Prof. Dr. A. Moritz 
PD Dr. A. Hoffmann 
 
Tag der Disputation: 10.04.2006 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
Philip und meiner Familie  
 
 
 
 
 
 
Die folgende Arbeit wurde durchgeführt mit freundlicher Unterstützung der  
RIEMSER Arzenimittel AG, Greifswald-Insel Riems 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Abbreviations: 
AD  Atopic dermatitis 
ALK  Allergologisk Laboratorium Kopenhagen, Denmark (manufacturer of 
allergenic extracts) 
Alt.a.  Alternaria alternata 
AP  Alkaline phosphatase 
Ara.h.  Arachis hypogaea 
Art.v.  Artemisia vulgaris 
Asp.f.  Aspergillus fumigatus 
B  Buffer 
Bet.v.  Betula verrucosa 
BSA  Bovine serum albumin 
Can.f.  Canis familiaris 
Clad.h. Cladosporium herbarum 
Der.f.  Dermatophagoides farinae 
Der f 1  Dermatophagoides farinae 1 allergen 
Der.p.  Dermatophagoides pteronyssinus 
Der p 1 Dermatophagoides pteronyssinus 1 allergen 
DL-A  Dog leukocyte antigen 
ELISA  Enzyme-linked immunosorbent assay 
FcεRI  High affinity receptor for IgE 
FcεRIα  Fragment of the extracellular portion of the high affinity IgE receptor alpha 
subunit 
Fel.d.  Felis domesticus 
Fel d 3  Felis domesticus 3 allergen (cystatin) 
Gly.m.  Glycine max 
HAL  Haarlem Allergenen Laboratorium, Amsterdam, Netherlands (manufacturer of 
allergenic extracts) 
HD  Human dander 
HDX  Human dander X (monoclonal antibody raised against human dander), Paul-
Ehrlich-Institut, Langen Germany  
Hom s 1 Homo sapiens 1 allergen 
mP30  Monoclonal antibody Paul-Ehrlich-Institut 30 (raised against birch pollen 
extract), Langen, Germany  
  
MW  Molecular weight 
NC  Nitrocellulose 
PEI  Paul-Ehrlich-Institut 
Pen.a.  Penaeus aztecus 
Pen.n.  Penicillium notatum 
Phl.p.  Phleum pratense 
PVDF  Polyvinylidenefluoride 
RAST  Radioallergosorbent test 
RBL test Rat basophil leukemia cell release test (assay) 
RT  Room temperature 
SDS-PAGE Sodium dodecyl sulphate polyacrylamide gel electrophoresis 
TBS  Tris buffered saline 
Tri.a.  Triticum aestivum 
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1 INTRODUCTION 
Allergic diseases, atopy in particular, have become increasingly important over the past 
decades. Presently, the prevalence of atopic diseases in human beings and dogs is estimated 
to exceed 30% and 10% respectively (OKUDAIRA, 1998; SCOTT et al., 2001). Similar to 
the situation in human beings, the increased prevalence in dogs is considered to be associated 
with environmental factors, such as the heightened exposure of pet dogs to common indoor 
allergens, house dust mites for example (HILLIER and GRIFFIN, 2001). Other important 
indoor allergens for human beings include the highly potent mammalian antigens derived 
from cats, dogs and other species. Conversely human dander (HD), which includes 
epidermals and other human proteins, is assumed to be of major clinical relevance in pet 
animals (SARIDOMICHELAKIS et al., 1999; STURE et al., 1995; VOLLSET, 1985; 
WILLEMSE and VAN DEN BROM, 1983).  
1.1 Allergy: current nomenclature and historical 
features 
Prior to dealing with the history of allergy, several common terms used in allergology will be 
defined. A “hypersensitivity response” is an exaggerated, often deleterious, response of the 
immune system to an antigen (OLIVRY et al., 2001). An “allergy” describes a disease state 
characterized by such a hypersensitivity response to an allergen. “Allergen” is a general term 
and simply refers to an antigen that favors the development of a hypersensitivity response 
(OLIVRY et al., 2001), though it is often used interchangeably with other terms such as 
“allergen molecule” and “major allergen” which further specify the allergen. “Allergen 
molecules” are able to bind IgE in at least one serum from a group of individuals with clinical 
symptoms of allergy against the specific allergen source. Most are water soluble proteins with 
molecular weights (MW) between 5 and 70 kilodalton (kDa) (IPSEN, 1998). “Major 
allergens” are allergen molecules that bind IgE from more than half the sera investigated. 
Half of the IgE-binding sera must bind the allergen strongly compared to the general binding 
pattern (IPSEN, 1998). 
Allergic reactions are phenomena which have been observed in medicine since antiquity. The 
first studies about allergic diseases in humans were published in the beginning of the last 
century (COCA and COOKE, 1922; COCA and GROVE, 1925; PRAUSNITZ and 
KÜSTNER, 1921; STORM VAN LEEUWEN W., 1922). In veterinary medicine a case of 
flea allergic dermatitis was first described in 1938 (KISSILEF), followed by a report in 1941 
(WITTICH) demonstrating the clinical manifestations of canine atopy in a dog with seasonal 
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allergic rhinitis. 
Attempting a more systematic description of allergic diseases COOMBS and GELL (1975) 
introduced a classification of allergic reactions responsible for clinical hypersensitivity and 
disease into four “types”. 
Type I hypersensitivity (anaphylactic reaction) is the most common hypersensitivity 
condition to occur in the dog. Type I reactions are those of immediate humoral 
hypersensitivity and are associated with mast cell or basophil degranulation. Anaphylactic 
reactions are responsible for allergic disorders such as urticaria and atopy (REEDY et al., 
2002).  
Type II hypersensitivity (cytotoxic hypersensitivity) is an antibody-dependent reaction. The 
antibody binds to cellular antigens or complement and causes the destruction of cells by 
phagocytosis following the activation of complement or killer cells. Type II hypersensitivity 
is the cause of certain autoimmune diseases, including pemphigus and autoimmune hemolytic 
anemia (REEDY et al., 2002). 
Type III hypersensitivity (Arthus reaction) is associated with the generation of immune 
complexes capable of activating the complement system, resulting in the damage of various 
tissues. It is also responsible for autoimmune diseases, e.g. systemic lupus erythematosus 
(REEDY et al., 2002). 
Type IV hypersensitivity (cell-mediated immune reaction) occurs when T-helper cells 
respond to a foreign antigen or small molecules bound to cells to form a complete antigen. 
The T-helper cell elaborates a variety of cytokines, thereby inducing inflammatory lesions. It 
takes between 24 and 48 hours from the time of contact with the offending antigen until the 
reaction is clinically manifest. Allergic contact dermatitis is an example for a type IV reaction 
(REEDY et al., 2002). 
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1.2 Canine atopy 
Atopy, a term first introduced in 1922 (COCA and COOKE), is a type I hypersensitivity 
reaction and is defined as a genetically predisposed tendency to develop IgE-mediated allergy 
to environmental allergens (OLIVRY et al., 2001). Atopic dermatitis (AD) is the most 
common manifestation of atopy in the dog. Atopic asthma, atopic rhinitis and atopic 
conjunctivitis are poorly defined and uncommon atopic diseases in dogs (OLIVRY et al., 
2001). 
1.2.1 Canine atopic dermatitis (AD) 
AD is defined as an inflammatory and pruritic allergic skin disease with characteristic clinical 
features (OLIVRY et al., 2001) and is considered to be the most or second most common 
cause of canine pruritus (CARLOTTI and COSTARGENT, 1994; REEDY et al., 2002; 
SCOTT et al., 2001). In textbooks the prevalence is estimated to be 3-15% and 10 % 
respectively (REEDY et al., 2002; SCOTT et al., 2001), though these figures are not based on 
reliable epidemiological data (HILLIER and GRIFFIN, 2001). 
1.2.1.1 Etiopathogenesis of AD 
AD is a complex syndrome affecting the non specific, cellular and humoral immune system in 
its entirety, though the genetically controlled production of IgE to common environmental 
allergens and its binding to mast cells is considered to play a major role in the development of 
the disease (REEDY et al., 2002). 
In 1921 it was shown that serum transferred from an allergic human to normal skin of a 
second individual by intradermal injection and subsequent intradermal injection of the 
allergen resulted in an anaphylactic reaction persisting at the site for over 48 hours (Prausnitz-
Küstner test) (PRAUSNITZ and KÜSTNER, 1921). The biological factor responsible for 
these reactions was first described in 1925 and termed “reagin” (COCA and GROVE). In the 
1960s and 70s “reagin” was biochemically identified as IgE and shown to be the major 
antibody with reaginic activity in man (BENNICH et al., 1969; ISHIZAKA and ISHIZAKA, 
1967). By this discovery an important step had been taken in understanding the pathogenetic 
mechanisms involved in hypersensitivity reactions. 
In veterinary medicine the first clinical case (WITTICH, 1941) of a dog suffering from AD 
also implicated a reaginic type of antibody. An anaphylactic shock was elicited when the dog 
underwent skin testing and serum from the same patient gave a positive Prausnitz-Küstner 
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test when transferred to a normal dog. In 1973 (HALLIWELL) an immunofluorescent study 
using rabbit sera against canine IgE demonstrated the association of IgE with mast cells. IgE-
mediated degranulation of mast cells, which are regarded as the key effector cells in the 
pathogenesis of allergic diseases such as AD (BROSTOFF and HALL, 1993), is the initial 
pathologic event in the anaphylactic reaction (REEDY et al., 2002). In a predisposed 
individual the first contact with the offending allergen results in the excessive secretion of 
IgE by B-lymphocytes (REEDY et al., 2002). IgE binds to high affinity FcεR1-receptors 
expressed on the mast cell and basophil cell membranes. Later exposure to the same allergen 
leads to cross-linking of cell-bound IgE antibodies (“bridging” phenomenon) which induces a 
complex cascade of biochemical reactions involving G proteins, tyrosine kinases, inositol-
triphosphate, protein kinase C, calcium channel activation and rearrangement of the 
cytoskeleton. This enables the mast cell granules to connect with the plasma membrane 
(HILL and MARTIN, 1998) and a host of inflammatory mediators are released (histamine, 
proteases, cytokines etc.) promoting the inflammatory response of the skin by participating in 
an interplay between the microvasculature and other inflammatory cells (HILL and OLIVRY, 
2001). A time frame of 10 to 20 minutes following contact with the offending allergen until 
appearance of clinical symptoms is characteristic of this hypersensitivity reaction. After five 
hours delayed reactions can occur as a consequence of eicosanoide activity and immigration 
of eosinophils (PRELAUD, 2002). Though this reaction cascade is intended to be protective, 
it is often directed towards harmless environmental antigens and contributes to the 
development of allergic diseases such as AD.  
Due to the fact that certain breeds are diagnosed with AD more frequently than others it is 
assumed that a genetic predisposition for AD exists (CARLOTTI and COSTARGENT, 1994; 
KOCH and PETERS, 1994; SARIDOMICHELAKIS et al., 1999; SCOTT, 1981; STURE et 
al., 1995; WILLEMSE and VAN DEN BROM, 1983). Many studies have focused on 
potential markers of AD, such as the antibody IgE, major histocompatibility haplotypes and 
the inheritance of the genes responsible for IgE production. VRIESENDORP and SMID-
MERCX (1975) compared IgE concentrations in the serum and dog leukocyte antigen (DL-
A) haplotypes in normal dogs to dogs with positive intradermal tests. Significant differences 
in the gene frequency of the different DL-A groups between normal and atopic dogs were not 
found. The combination of the DL-A haplotype 3 and R 15 was found significantly more 
often in atopic dogs than normal dogs, whereas the DL-A haplotype 9,4 was found 
significantly less frequently in atopic dogs. The authors hypothesized the former combination 
to increase the susceptibility to AD, whereas the latter was postulated to protect the individual 
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from the disease. IgE concentrations between the two groups of dogs showed no significant 
differences and there was no evidence of a relationship between IgE levels and DL-A 
haplotypes. DE WECK et al. (1995; 1997) demonstrated that repeated sensitization of 
selected beagle dogs within the first week of life is able to trigger high IgE levels and the 
authors suggested a dominant inheritance pattern for the development of high IgE levels. 
Therefore, the full potential of a high IgE response gene seems to be fulfilled only under 
certain conditions, such as early and repeated allergen exposure. This indicates that both 
environmental and genetic factors are of central importance for the development of high IgE 
levels (SOUSA and MARSELLA, 2001). ZUNIC (1998b) investigated dogs with high 
allergen-specific IgE levels („high responder“ dogs) regarding their reactions to intradermal 
testing and the development of clinical lesions of AD. The dogs showed immediate skin test 
reactivity but only some of them developed clinical lesions of AD after allergen exposure. 
The author concluded that the development of clinical disease is subject to an additional 
genetic control.  
Although IgE indisputably plays a pivotal role in allergic asthma and rhinitis, critics cite the 
fact that many clinically normal individuals show a positive intradermal test as well as 
elevated allergen-specific serum IgE levels (HALLIWELL and DEBOER, 2001). A recent 
study demonstrated increased dust mite-specific IgE concentrations in the serum of clinically 
normal dogs (LIAN and HALLIWELL, 1998). Another study showed that IgE is also 
inducible in dogs via artificial sensitization, though disease is not necessarily a consequence 
(JACKSON et al., 1996). Many plausible explanations for this phenomenon have been 
suggested. In humans evidence for a functional heterogeneity of IgE antibody in terms of its 
ability to mediate histamine release through interaction with a histamine releasing factor was 
published in 1995 (MACDONALD et al.). In veterinary medicine the possibility that canine 
IgE might be heterogeneous received support from a study performed by PENG et al. (1997). 
Two biologically active forms of IgE were revealed, underlining the possibility of a 
relationship between different IgEs and the allergic response in the dog. A second theory 
suggests differences in mediator releasability of mast cells between normal and atopic dogs. 
Evidence for this was published in a study where histamine release from basophils of atopic 
dogs, from normal dogs and from dogs in which IgE antibodies to Dermatophagoides farinae 
(Der.f.) was induced experimentally. The leukocytes of atopic dogs had a greater tendency to 
release histamine than did those of normal or artificially sensitized dogs, both to allergen and 
anti-IgE (JACKSON et al., 1996). Other in vitro studies have also shown that the releasability 
of mast cells is enhanced in those isolated from atopic dogs as compared to mast cells isolated 
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from normal dog skin (DE MORA et al., 1996). One explanation for enhanced mast cell 
releasability  suggests that up regulatory factors are produced in AD to prime mast cells for 
subsequent allergen challenge (HILL and OLIVRY, 2001). Mast cells are known to possess 
c-kit, the receptor for stem cell factor (LONDON et al., 1996). Experiments performed by 
HAMMERBERG et al. (2001) suggest that dermal stem cell factor secretion could potentize 
histamine release following IgE receptor cross-linking and thus, be one of the explanations 
for the inherent mast cell hyperexcitability observed in canine AD. 
1.2.1.2 Clinical manifestations of AD 
For veterinary medicine the clinical signs of canine AD were initially described in 1971 
(HALLIWELL and SCHWARTZMAN). Primary symptoms are pruritus and the appearance 
of atopic lesions at an age of 6-12 months, often seasonally at first. Certain areas of the body 
are predisposed, such as the face, extremities, axillae and ventrum (GRIFFIN and DEBOER, 
2001). Whether primary lesions as such exist, remains unclear. Many studies have described 
the appearance of primary lesions (CHAMBERLAIN, 1974; GRIFFIN, 1993; ROCKEY and 
SCHWARTZMAN, 1967), while other studies negate the occurrence of primary lesions 
(HALLIWELL and SCHWARTZMAN, 1971; SCOTT, 1981). However, dermatologists 
agree that if a primary lesion exists, it consists mainly of erythema. Secondary lesions 
resulting from chronic pruritus, automutilation, chronic inflammation and secondary bacterial 
infections are a common finding in atopic patients (REEDY et al., 2002; SCOTT et al., 2001; 
WILLEMSE and VAN DEN BROM, 1983). 
1.2.1.3 Diagnosis of AD 
Although history and clinical findings are suggestive of AD, symptoms in both humans and 
dogs are extremely variable and there is no pathognomonic feature permitting a definitive 
diagnosis (DEBOER and HILLIER, 2001a). The first step towards a diagnosis is the 
fulfillment of a minimum of clinical major criteria, i.e. pruritus, the location and appearance 
of lesions and minor criteria (WILLEMSE, 1988), such as the age of onset. The most recent 
criteria were defined by PRÉLAUD et al. (1998). In the second step, important differential 
diagnosis such as flea allergic dermatitis and cutaneous adverse food reactions must be ruled 
out (SCOTT et al., 2001). In vivo or in vitro tests are used in a third step as an adjunct to the 
clinical diagnosis of AD and to identify the allergens to which the animal is hypersensitive. 
The identification of the relevant allergens enables the clinician to employ specific allergen 
avoidance measures or allergen-specific immunotherapy (REEDY et al., 2002).  
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In vivo tests measure the mast-cell bound IgE and the resulting skin reaction produced by 
degranulation of the mast cells following intracutaneous application of the offending allergen. 
In vitro tests measure immunoreactants, particularly total serum IgE and allergen-specific 
IgE. Studies have shown total IgE levels between clinically healthy and atopic dogs not to be 
significantly different (HILL et al., 1995; OLIVRY et al., 1996). In a recent study RACINE et 
al. (1999) investigated total serum IgE concentrations in a beagle population and found that 
sex and age significantly influence IgE values. The authors hypothesized that breeds must be 
evaluated singly for total IgE concentration to be of diagnostic value. Furthermore, routine 
vaccination procedures and/or the presence of parasites may also influence total serum IgE 
concentrations in dogs (HILL et al., 1995).  
Semiquantitative serum allergen-specific IgE assays were first reported in 1978 
(HALLIWELL and KUNKLE) and have become very popular over the past few years. The 
semiquantitative determination of circulating allergen-specific IgE can be performed with 
commercially available tests (DEBOER and HILLIER, 2001b) based on enzyme-linked 
immunosorbent assays (ELISA), radioallergosorbent tests (RAST) or solid phase 
nitrocellulose (NC) -immunodot tests. These assays have several advantages compared to the 
intradermal test. Clipping and sedation of the patient are unnecessary and only a small 
amount of blood is required for testing (WASSOM and GRIEVE, 1998). Serological assays 
are also less time-consuming than the intradermal test and the veterinarian must not invest in 
the test materials that could become dated respectively expired. Furthermore the test is 
harmless, as there is no risk of an anaphylactic reaction, a rare complication of in vivo testing 
(REEDY et al., 2002). 
Studies comparing the serum IgE to specific allergens in the atopic dog population (table 1) 
reveal highly varying results (HILL and DEBOER, 2001).  
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Table 1: Elevated serum IgE to selected allergenic extracts in atopic dogs in six studies 
(HILL and DEBOER, 2001); Figures indicate the percentage of dogs with 
elevated IgE levels within the designated study 
Study* 
Allergenic extracts 
A B C D E F 
Dermatophagoides farinae 86 90 90 44 32 62 
Dermatophagoides pteronyssinus 86 90 90 44 32 62 
Human dander - 60 0 - - - 
Birch 54 70 0 - - - 
Cat epithelium - 70 0 0 - 0 
Mugwort - 10 10 - - - 
Timothy 83 80 0 - - - 
Penicillium 100 90 30 - - - 
Aspergillus 81 100 20 - - 0 
Alternaria 100 100 20 2 4 0 
*) Study References: A: (KLEINBECK et al., 1989); B: (BOND et al., 1994) 
ELISA data from test A; C: (BOND et al., 1994), ELISA data from test B; 
D: (HAMMERLING and DE WECK A.L., 1998) Immunodot data; 
E: (HAMMERLING and DE WECK A.L., 1998) ELISA data; F: (ZUNIC, 
1998a) Immunodot data, “-“: allergenic extracts not included in the study 
 
At first glance it is not clear, whether the high variations in the percentage of dogs with 
elevated allergen-specific IgE reflect true differences in the respective sensitization patterns 
or whether varying sensitivities and specificities of the individual IgE-assays are responsible 
for this phenomenon. For example, the proportion of dogs with elevated allergen-specific 
serum IgE to the indoor allergen HD, vary from 0% in one ELISA to 60% in a second 
(BOND et al., 1994). Allergen-specific IgE levels to outdoor allergens show the same 
discrepancies. Elevated timothy-specific IgE levels for example, ranges from 0% to 83% 
(BOND et al., 1994; KLEINBECK et al., 1989). Though inconsistencies of results regarding 
outdoor allergens may be explained by the variable geographical regions in which the studies 
were performed as well as differing lifestyles, other explanations must be found for indoor 
allergens (HILL and DEBOER, 2001). Both test and patient factors are capable of influencing 
test results. Of the test factors the allergenic extract used in the assay plays a central role. In 
human allergology laboratories are therefore increasingly relying on biologically-
standardized allergenic extracts or recombinant-source major allergens epitopes for their 
assays. This standard has not yet been established in veterinary medicine (DEBOER and 
HILLIER, 2001b). Allergenic extracts from different manufacturers are not standardized and 
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can contain significantly different concentrations of major allergens, consequently leading to 
varying assay results (MEYER et al., 1994; REEDY et al., 2002). Veterinary laboratories also 
lack standard quantitative reference preparations of allergen-specific IgE. Because the assays 
are semiquantitative, results are difficult to compare (DEBOER and HILLIER, 2001b). 
Furthermore mandatory or voluntary regulatory steps to maintain quality control as there are 
in the United States for human laboratories (DEBOER and HILLIER, 2001b) have not yet 
been established. One report demonstrates that results regarding the same serum sample sent 
to the same laboratory on different dates varied substantially (PLANT, 1994). Another major 
problem of allergen-specific IgE assays is the specificity of the anti-dog IgE used. Assays 
using monoclonal anti-IgE detection antibodies (DERER et al., 1998; HAMMERLING and 
DE WECK A.L., 1998) should be preferred to the less specific polyclonal anti-IgE detection 
reagents, which many companies and laboratories still use in their tests (BOORD, 2000; 
SAEVIK et al., 2003). Polyclonal anti-IgE reagents tend to cross-react with IgG which 
exceeds IgE concentrations in serum by far (HILL et al., 1995), therefore potentially causing 
false-positive results. One recently introduced highly specific assay uses a recombinant 
fragment of the extracellular portion of the human high affinity IgE receptor alpha subunit 
(FcεRIα) as a detection reagent, which does not cross-react with IgG (STEDMAN et al., 
2001; WASSOM and GRIEVE, 1998). Further factors influencing test results include the 
reacting phase of allergen and the detection reagent employed. Though the reacting phase of 
allergen, mostly solid phase supports such as microtitre plates, cellulose or NC strips/discs 
(LIAN and HALLIWELL, 1998; ZUNIC, 1998a) probably have a negligible effect on test 
results, the detection reagents used may influence assay results in ELISAs. Detection reagents 
are mostly enzymes coupled to an antibody. MARI et al. (1999) suspect that patient serum 
IgE directed against common, non mammalian carbohydrate determinants may bind to 
carbohydrate moieties possibly available in a plant derived detection enzyme such as horse 
radish peroxidase, occasionally resulting in false positive reactions. 
In human beings it is known that patient factors such as age, the season of year and prior 
immunotherapy can influence test results (OWNBY, 1998). There is only limited information 
available concerning these factors in the dog. Data regarding the effect of the season are 
variable. Some authors revealed seasonal variation in allergen-specific IgE (HALLIWELL 
and KUNKLE, 1978), while one study found levels of allergen-specific IgE to remain 
unchanged for two months following the pollen season (MILLER, JR. et al., 1992). The same 
study also showed that treatment with corticosteroids does not affect in vitro serum allergen-
specific IgE assays if administered at moderate doses for up to two months. Therefore, 
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depending on what time of year the studies were performed in and patient inclusion criteria, 
variable test results in the studies are to be expected. Serum factors have also been reported to 
influence test results. The level of blocking IgG is felt to be an important cause of false 
negative test results (GRIFFIN, 1989; WOJDANI et al., 1985) and in humans, high total 
serum IgE levels are associated with more false-positive RAST results (CAPRIO et al., 
1983). Total serum IgE levels in dogs are considerably higher, 190,000 ng/ml in normal dogs 
versus 700 ng/ml in atopic humans. Therefore the “average dog” has 20 to greater 200 times 
the background of IgE found in humans. The high levels of IgE in the canine are believed to 
be the result of their exposure to external and internal parasites. If results from humans are to 
be extrapolated in dogs, these high IgE levels may lead to false-positive results (GRIFFIN, 
1989). Lastly, non IgG serum blockers have been hypothesized to affect test results as well 
(WOJDANI et al., 1985).  
In a comprehensive study DeBoer and Hillier (2001b) compared the test sensitivity and 
specificity of serologic allergen-specific IgE assays (table 2).  
Table 2: Evaluation of sensitivity and specificity of in vitro IgE assays in dogs 
(DEBOER and HILLIER, 2001b)  
Study reference Number of dogs Sensitivity Specificity
(CODNER and LESSARD, 1993) 41 100 0 
(MILLER et al., 1993) 17 43-86* 33-100* 
(BOND et al., 1994) 30 100 0-10 
(GINEL et al., 1998) 48 72 42 
(HAMMERLING and DE WECK A.L., 1998) 76 45-100* 78-92* 
(WASSOM and GRIEVE, 1998) 50 64-100* 79-100* 
(ZUNIC, 1998a) 48 44-78* 35-97* 
(MUELLER et al., 1999) 84 90 92 
(SAEVIK et al., 2003) 60 54 84 
*) Where ranges are given, the reported results varied by specific allergen or allergen group, by 
test method, or by criteria for analysis 
 
The apparently dominant problem of low test specificity, i.e. positive in vitro test results in 
conjunction with a negative intradermal test (the gold standard of diagnosis) can be the 
consequence of either a “technical” or a “biological” false positive result (DEBOER and 
HILLIER, 2001b). “Technical” false positive results may be due to nonspecific binding to 
proteins or carbohydrates in the extract, the measurement of other immunoglobulin isotypes 
or non-allergen-specific IgE. “Biological” false positive results are the consequence of 
1 INTRODUCTION 
 11  
genuinely elevated allergen-specific IgE levels in clinically healthy dogs for which possible 
reasons have been dealt with in detail in chapter 1.2.1.1. Low test sensitivity, i.e. a negative in 
vitro test result in conjunction with a positive intradermal test result, can be due to either a 
false positive intradermal test or the interference with IgE measurement by circulating IgE 
immune complexes (VASSELLA et al., 1990). Even though the intradermal test was 
employed as the “gold standard” of diagnosis in all studies shown above it is important to 
remember that it does not necessarily reliably reflect the clinical status of the patient 
(DREBORG, 1993; PASTORELLO, 1993). For example, positive intradermal test results in 
normal dogs are a common finding (CODNER and TINKER, 1995; LIAN and 
HALLIWELL, 1998) and can be due to mast cell-bound IgE leading to degranulation during 
skin-testing though the animals do not exhibit clinical signs of AD (“false positive” reactions) 
(AUGUST, 1982; LIAN and HALLIWELL, 1998). Apart from subclinical hypersensitivity 
(PASTORELLO, 1993), clinically irrelevant reactions can also be due to per se irritant 
substances eliciting false positive reactions in non atopic dogs (AUGUST, 1982) or the 
necessity of other factors than mast cell-bound IgE, i.e. allergen-specific IgGd (WILLEMSE 
et al., 1985), to cause AD. In order to reliably calculate the test sensitivity and specificity of 
allergen-specific IgE assays a reliable “gold standard” of allergy diagnosis is required. 
Unfortunately, the only indisputably reliable “allergy test” is a provocation test, which is an 
extremely difficult test to perform and can cause dangerous anaphylactic reactions in the 
patient (PRELAUD, 2002).  
1.2.2 Canine AD and cutaneous adverse food reactions 
The term “adverse food reaction” refers to any clinically abnormal response attributed to the 
ingestion of a food or food additive. “Food allergy reactions” are considered a subgroup of 
adverse food reactions and are defined as an immunologically mediated adverse food reaction 
to food unrelated to any physiological effect of the food or food additive (ANDERSON, 
1986). Food allergy in humans is an IgE-mediated hypersensitivity and a clear relationship 
between food allergens and AD has been established (SICHERER and SAMPSON, 1999). In 
veterinary medicine reports from the late 60´s and 70´s suggest that up to 30% of dogs with 
AD exhibit concurrent adverse food reactions (CHAMBERLAIN, 1974). In later studies less 
dogs with AD were reported to show concurrent adverse food reactions (CARLOTTI and 
COSTARGENT, 1994; SARIDOMICHELAKIS et al., 1999). In contrast 13-30% of dogs 
diagnosed with cutaneous adverse food reactions have been reported to exhibit concurrent 
AD (CARLOTTI et al., 1990; CARLOTTI and COSTARGENT, 1994; ROSSER, 1993; 
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WHITE, 1986). In dogs however, the pathogenesis of cutaneous adverse food reactions 
remains controversial. Several studies of canine models of IgE-mediated food 
hypersensitivity (DE WECK, 1997; TEUBER et al., 2002) have been published, as well as 
reports of spontaneous IgE-mediated food allergy in dogs (ISHIDA et al., 2003; JACKSON 
and HAMMERBERG, 2002). However, IgE-mediated hypersensitivity as the most common 
pathogenetic mechanism of cutaneous clinical signs of food allergy in dogs remains to be 
proven (HILLIER and GRIFFIN, 2001). 
All foods can cause adverse reactions (REEDY et al., 2002) and lists of relevant foods differ 
depending on the geographic area and culinary habits (BAKER, 1990). Foods with the 
highest potential for causing adverse reactions are those which contain the most protein and 
are fed frequently. Studies have proven that the higher the intake of any one food, 
independent of the protein involved, the higher the probability of developing an adverse 
reaction (CARLOTTI et al., 1990; JEFFERS et al., 1996). Food antigens are usually protein 
molecules with a MW of 10 kDa or more (PRELAUD, 2002). Potentially relevant foods for 
dogs include most meats (REEDY et al., 2002), soy, a protein included in many low-quality 
pet foods (HILL et al., 2000), certain grains, such as components of wheat and barley 
(PRELAUD, 2002), all fruits and vegetables, haptens and food additives. In contrast to 
humans, peanuts as a representative of the family of legumes are a widely unrecognized 
potential source of cutaneous adverse food reactions in dogs. Dogs ingest peanut antigens 
when fed commercial pet foods containing peanut hulls added as prebiotic agents due to their 
oligosaccharid content (FLICKINGER and FAHEY, JR., 2002). Sea food can also cause 
cutaneous adverse food reactions. Fish meat itself may elicit an adverse reaction or be 
contaminated by large amounts of histamine due to spoiling or storage at high temperatures 
(REEDY et al., 2002). Crustacean proteins, common food allergens for humans (LEHRER et 
al., 2003) are often an ingredient of pet foods and in analogy to humans may elicit cutaneous 
adverse food reactions in dogs.  
Clinical manifestations of cutaneous adverse food reactions involve mainly the skin and the 
digestive tract (BAKER, 1990). Intestinal signs may be acute or chronic and vary from mild 
to severe. The most important dermatological signs are urticaria and pruritus, which is 
generally intense and may or may not be accompanied by skin lesions (BAKER, 1990). 
Similar as in AD, onset of the disease is at a young age and the predilection sites are identical 
(PRELAUD, 2002). Otitis and secondary bacterial and Malassezia infections frequently occur 
(REEDY et al., 2002; SCOTT et al., 2001). Therefore it is difficult to distinguish between the 
two diseases on a clinical basis alone.  
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The diagnosis of cutaneous adverse food reactions are based on the performance of exclusion 
diets, serum allergen-specific IgE assays, intradermal tests, the gastroscopic food sensitivity 
test and colonoscopic allergen provocation (ALLENSPACH et al., 2006; BAKER, 1990; 
PRELAUD, 2002; REEDY et al., 2002). The exclusion diet is considered the “gold standard” 
method of diagnosis (SAMPSON, 1988). In the first step, the animal should receive a novel 
protein over a period of at least six weeks during which no other foods may be fed. In a 
second step, the dog is challenged with the foods it received prior to the elimination trial. If 
the condition worsens, an adverse food reaction can be suspected (BAKER, 1990; 
PRELAUD, 2002). Serum allergen-specific IgE assays for foods are controversial. In human 
medicine some studies report low sensitivity and low specificity (SANZ et al., 1996), while 
other authors claim good sensitivity, but poor specificity of such assays (SICHERER and 
SAMPSON, 1999). Published studies of food allergen-specific IgE assays in dogs, found 
them to be insensitive, nonspecific, and unreliable for the diagnosis of adverse food reactions 
(JEFFERS et al., 1991; MUELLER and TSOHALIS, 1998). Because it is speculated that not 
all adverse food reactions in dogs are IgE-mediated, and other pathogenetic mechanisms may 
be involved, an IgE assay would per se fail to detect some dogs with adverse food reactions 
(DEBOER and HILLIER, 2001b).  
1.3 Allergens for dogs 
The term “allergen” is a general term and is often used interchangeably with “allergenic 
extract” and “allergen source”. An allergen is an antigen that favors the development of a 
hypersensitivity response (OLIVRY et al., 2001). Clinically relevant allergens include a 
variety of indoor and outdoor allergens, a selection of which will be discussed in the 
following paragraph. 
1.3.1 Clinically relevant allergen sources 
Many studies have identified clinically relevant allergens for dogs either by demonstration of 
skin test reactivity to the offending allergens and/or measurement of allergen-specific IgE or 
IgGd levels in serum (BOND et al., 1994; CARLOTTI and COSTARGENT, 1994; CODNER 
and TINKER, 1995; DEBOER, 1989; HAMANN et al., 1996; HAMMERLING and DE 
WECK A.L., 1998; KLEINBECK et al., 1989; KOCH and PETERS, 1994; NESBITT, 1978; 
NESBITT et al., 1984; SARIDOMICHELAKIS et al., 1999; SCOTT, 1981; STURE et al., 
1995; VOLLSET, 1985; WILLEMSE et al., 1985; WILLEMSE and VAN DEN BROM, 
1983; ZUNIC, 1998a). The spectrum of relevant allergens appears to be similar to that of 
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human beings including the outdoor allergens tree, weed and grass pollens and the indoor 
allergens mold spores, epithelial antigens and mites as components of “house dust” (IPSEN, 
1998). 
House dust has been recognized as a major perennial allergen for over 80 years (COCA and 
COOKE, 1922; KERN, 1921) and has been reviewed by a multitude of scientists 
(BERRENS, 1970; SUTHERLAND, 1942; WALZER, 1938; WOOD et al., 1988). House 
dust is a complex mixture that may contain a variety of potent allergens (WOOD et al., 1988). 
Apart from dust mite antigens of the Dermatophagoides species, dog, cat, human and mold 
antigens are highly prevalent in house dust (WOOD et al., 1988).  
Der.f. in particular, appears to be among the most common allergens in Europe to elicit 
positive reactions in dogs with AD (HILL and DEBOER, 2001; LIAN and HALLIWELL, 
1998; STURE et al., 1995). Since allergen exposure is necessary for sensitization, a recent 
study performed quantitation of house dust mites and house dust mite allergens in the 
microenvironment of dogs (RANDALL et al., 2003). It was found that Der.f. is the most 
common mite allergen in the household microenvironment of dogs, a finding which may 
explain the higher prevalence of positive reactions to Der.f. than to Dermatophagoides 
pteronyssinus (Der.p.) (BENSIGNOR and CARLOTTI, 2002; CARLOTTI and 
COSTARGENT, 1994; LIAN and HALLIWELL, 1998; STURE et al., 1995; VOLLSET, 
1985). In contrast, sensitization to Der. p. is more frequent in human beings. Another reason 
for this phenomenon may be different major allergens recognized by man and dog (MCCALL 
et al., 2001; NUTTALL et al., 2001; WEBER et al., 2003).  
A further very important antigenic component of house dust is constituted by epidermals and 
other proteins originating from humans. The term commonly used for these antigens is human 
dander (HD). An adult produces about 5 g of dander per week (KLIGMAN, 1964) and house 
dust always contains a certain percentage of HD. It has been shown that the residual allergen 
activity of house dust is due almost entirely to its HD content (4%) (VOORHORST, 1977). 
The allergenic potential of HD as an autoallergen has been known for decades. STORM VAN 
LEEUWEN (1922) was among the first to draw general attention to the specific human 
dandruff allergen as an important factor in human atopy. A study performed in 1941 
(HAMPTON and COOKE) showed positive skin reactions to human dandruff extract and 
demonstrated skin sensitizing antibodies in the sera of these patients. SIMON, apart from 
various studies showing the significance of human epidermals in infantile eczema (1944), 
demonstrated that the allergen is particularly concentrated in the scales of the human scalp 
(SIMON, 1947). One study tried to partially purify the HD allergen by the method of salting 
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out fractionation (BERRENS and YOUNG, 1964). There have also been several attempts to 
isolate the relevant proteins in HD extracts via various immunochemical methods. In 1988 
(YU et al.) an aqueous crude HD extract was divided into four fractions by use of high-speed 
gel filtration chromatography. Sodium dodecyl sulfate polyacrylamide gel electrophoresis 
(SDS-PAGE) and Coomassie staining demonstrated that fraction II contained two proteins 
with apparent MW of approximately 10 kDa and 13 kDa, respectively. Fraction I showed two 
major protein bands of which the apparent MW were located at 59 kDa and 52 kDa. 
VALENTA et al. (1998) characterized human allergen with serum IgE from patients with 
AD. The IgE-binding protein was shown to have an apparent MW of 55 kDa and was termed 
Hom s 1. Hom s 1 exhibited a broad cellular and tissue reactivity (skin, 
lung>>gastrointestinal tract>>muscle, brain). In veterinary medicine human epidermals and 
proteins are recognized as potentially important allergens in AD. WILLEMSE and VAN 
DEN BROM (1982) were the first to establish a skin threshold concentration for the use in 
intradermal tests in the canine patient. HD has been included in many studies investigating 
the frequency of elevated allergen-specific IgE (table 1) and positive intradermal test 
reactivity (table 3) in the atopic dog population. In some European studies, among house dust 
mite and house dust not otherwise specified, the human dandruff antigen has even been 
discussed to be of central importance in AD (SARIDOMICHELAKIS et al., 1999; STURE et 
al., 1995; VOLLSET, 1985; WILLEMSE and VAN DEN BROM, 1983). Possible reasons for 
the very variable results (table 1 and 3) such as the lack of standardization of allergenic 
extracts and false positive and false negative results in in vitro and in vivo tests have been 
dealt with in chapter 1.2.1.3.  
 
Table 3: Percentage of atopic dogs reacting to HD in intradermal tests (HILL and 
DEBOER, 2001) 
Study* 
Allergen A B C D E F G H I J 
HD 17 50 40 42 60 36 66 68 55 36 
*) Study references: A: (NESBITT, 1978); B: (SCOTT, 1981);C: (WILLEMSE 
and VAN DEN BROM, 1983); D: (VOLLSET, 1985); E: (BOND et al., 1994), 
skin testing data; F: (CARLOTTI and COSTARGENT, 1994); G: (KOCH and 
PETERS, 1994); H: (STURE et al., 1995), data from Edinburgh group; I: 
(STURE et al., 1995), data from London group; J: (SARIDOMICHELAKIS et 
al., 1999) 
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1.3.2 Allergenic extracts 
For use in the diagnosis and therapy, allergenic extracts must be prepared from clinically 
relevant allergen sources. “Allergenic extract” is a frequently used technological term. It 
refers to the intermediate product after extraction of the allergenic substances from the raw 
allergen source materials that patients are exposed to under normal conditions (IPSEN, 1998) 
and prior to the final preparation of test allergens and allergens for therapeutic purposes. 
Allergenic extracts are complex biological substances and are comprised of many different 
proteins (IPSEN, 1998). Many factors during the process of extraction and handling influence 
the composition, biological activity and stability of allergenic extracts. In order to ensure 
reliable and reproducible results in diagnosis and therapy, standardization is essential 
(DREBORG, 1993). A standardized allergenic extract must reflect a relevant allergen source 
material and be of a known composition and total allergenic potency, which is constant 
between batches (DREBORG, 1993).  
1.3.2.1 Preparation of allergenic extracts 
Allergenic extracts should have the specific ability to detect all possible IgE specificities 
directed against any constituent from a given allergen source (IPSEN, 1998). The preparation 
of an allergenic extract must neither denature the proteins or allergens nor significantly alter 
the ratio between the individual components. The time needed to obtain a representative 
extract is a compromise between denaturation and desired yield (IPSEN, 1998). 
All extracts prepared in multiple dose containers must contain a substance to inhibit microbial 
growth and preserve the potency of the allergenic extracts in the diluents. Though 
phenolization can cause extracts to lose potency (NELSON, 1981), especially those with 
weaker dilutions at high temperatures (REEDY et al., 2002), phenole is generally included in 
allergenic extracts in a concentration of 0.4% to prevent contamination (PRELAUD, 2002). 
Glycerole is one of the most commonly used preservatives and was introduced in 1917 
(CLOCK, 1917). In a concentration of 50% or more, glycerole inhibits microbial growth 
(ROSENAU, 1903) and in addition, has an excellent effect on the stability of allergenic 
extracts. Extracts with 50% glycerole can be kept at +4°C for several years (PRELAUD, 
2002). Prior to intradermal use of glycerole preserved extracts a dilution to a 0,5% glycerole 
content is necessary, which is a concentration well tolerated by animals (PRELAUD, 2002). 
Higher concentrations can cause local reactions such as erythema, exudation and necrosis 
(SCOTT et al., 2001; VAN WINKLE, 1981). 
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1.3.2.2 Allergen standardization 
In human medicine an increasing part of the allergenic extracts is now standardized and 
should meet the following requirements (IPSEN, 1998). Every batch of allergenic extract 
should be evaluated regarding allergen composition and content of specific allergens to 
ensure constant ratios. Qualitative methods include SDS-PAGE and immunoblotting, 
isoelectric focusing and crossed immunoelectrophoresis. The quantitative determination of 
specific allergens can be performed by immunoelectrophoresis and ELISA. Furthermore 
allergenic extracts must have a consistent total allergenic activity, measured by in vivo and in 
vitro methods. Recently, a new method was introduced for in vitro measurement of allergenic 
potency (HOFFMANN et al., 1999). The rat basophil leukemia cell mediator release assay 
(RBL test) is based on a rat basophil leukemia cell line which can be sensitized with murine 
sera or monoclonal IgE antibodies specific for the allergen. Challenge with the allergenic 
extract induces cross-linking of the monoclonal antibodies and degranulation of the cells. An 
enzyme (β-hexosaminidase) released from the cells induces a colorimetric reaction with the 
added substrate cocktail and is measured photometrically. 
Standardized extracts are not available in veterinary medicine and those standardized for 
human use are of limited value in dogs, because other species may recognize a variety of 
different major allergens in the crude extract. Therefore false positive and negative results 
during intradermal testing and allergen-specific serum IgE assays using extracts for human 
beings are possible (HILLIER and DEBOER, 2001). So far very few major allergens 
including house dust mites (MCCALL et al., 2001; NUTTALL et al., 2001), cat flea 
(MCDERMOTT et al., 2000) and Japanese cedar (SAKAGUCHI et al., 2001) antigens have 
been identified for the dog by Western blotting using serum from allergic dogs as probes for 
the detection of relevant allergenic proteins in the crude extract. As mentioned before, apart 
from determining major allergens in allergenic extracts, standardization for use in intradermal 
tests also includes biological standardization via intradermal testing (IPSEN, 1998). Dogs 
show marked differences in skin reactivity depending on sex (AUGUST, 1982), coat 
pigmentation (AUGUST, 1982) and age (AUGUST, 1982; SCHWARTZMAN, 1984; 
WILLEMSE and VAN DEN BROM, 1982) as well as differences in skin thickness 
depending on the breed (SCHÄRER, 1997) and age (BAKER, 1967; SCHÄRER, 1997). 
Therefore biological standardization of allergens for use in the canine patient is an extremely 
difficult procedure. Because of these problems standardized extracts are not available for use 
in veterinary medicine (HILLIER and DEBOER, 2001). 
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1.4 Objective 
The antigen challenge by perennial indoor allergens is most probably the main cause of atopy 
in dogs. In addition to mites and molds, human proteins are a major component of the 
antigenic materials present in house dust and are thought to play an important role in the 
development of canine AD. Two crucial points suggest human proteins to be of clinical 
importance in dogs: 
Firstly, contact with human epidermals and proteins are chronic since these antigens are 
ubiquitous in an indoor environment. Secondly, human dandruff belongs to the family of 
mammalian proteins which per se harbours highly potent allergenic properties.  
In order to perform further studies regarding the sensitization of dogs to human epidermals 
and proteins a well characterized HD extract is essential. Therefore an important issue of this 
study is the characterization of two available HD extracts, which complete a representative 
panel of allergens used to screen four typical dog populations for their allergen-specific IgE 
profiles. A further aim is the identification of specific IgE-binding proteins in HD extract and 
the elucidation of their biological nature. 
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2 MATERIAL AND METHODS 
2.1 Dog populations 
In this study the serological data of 178 dogs were analyzed. The dogs originated from four 
groups. In detail the first group was composed of “multi source” atopic dogs (n=88), the 
second group included dogs with skin diseases other than atopy (n=20) and the third and 
fourth group were comprised of healthy “household” (n=30) and healthy kenneled beagles 
(n=40), respectively. 
2.1.1 “Multi-source” atopic dogs 
The “multi-source” atopic dogs (group I) included a total number of 88 dogs, 55 of which 
were composed of a cohort of pet dogs seen by general practice veterinarians with clinical 
symptoms suggestive of AD. The sera of these dogs had been submitted for allergen-specific 
IgE screening at BIOCONTROL laboratories, Mainz, Germany. The other 33 dogs were 
presented at the Clinic for Small Animals, University of Berlin, Germany and were diagnosed 
with AD by a combination of history, clinical findings and elimination of important 
differential diagnosis. The intradermal test was employed as an adjunct to diagnosis. The 
signalment and intradermal test data were not available for this group of dogs. 
2.1.2 Dogs with skin diseases other than atopy  
The second group (group II) was comprised of 20 dogs presented at the Small Animal Clinic, 
University of Giessen, Germany. These dogs were subject to skin diseases other than AD 
including infestation with parasites (n=8), bacterial (n=10) and fungal skin infections (n=2). 
The diagnosis was made by identification of the underlying cause using skin scrapings, 
cytology, bacterial and fungal culture and resolution of clinical signs following specific 
treatment. Nine of these dogs were female and eleven were male. Various breeds were 
represented and the ages ranged from three months to 11 years. 
2.1.3 Healthy “household” dogs  
The third group (group III) was one of the control populations and was composed of 30 staff- 
and client-owned physically healthy dogs kept in household conditions without any present or 
prior history of skin problems. 12 male and 18 female dogs of various breeds were included 
with ages ranging from six months to 11 years. The client-owned animals were presented at 
the Small Animal Clinic, Internal Medicine, University of Giessen, Germany as blood donors. 
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2.1.4 Healthy beagle population 
40 beagle dogs, maintained at HARLAN Winkelmann GmbH Borchen, Germany for breeding 
purposes, were the second control population (group IV). 20 of these dogs were female and 20 
were male, the ages of which ranged from seven months to nine years. The dogs were kept in 
groups of six on a concrete floor and contact was limited to the personnel in charge of the 
dogs. 
2.2 Serum collection 
Serum samples were obtained from all dogs. 145 sera were collected between November 2000 
and November 2003. 33 sera of the “multi-source” atopic dog population were collected 
between 1991 and 1994. Blood was drawn by jugular venipuncture or by venipuncture of the 
Vena cephalica or Vena saphena. The samples were left to clot at room temperature, 
centrifuged at 1000 rounds per minute for three minutes and stored at –20°C. 
2.3 Allergenic extracts 
Eleven allergenic extracts were chosen for the study (table 4). Except for shrimp, peanut, soy, 
birch and HD, the allergenic extracts were stock extracts from ALLERGOPHARMA, 
Joachim Ganzer KG, Reinbek, Germany standardized for use in human beings. Shrimp, 
peanut, soy and birch extract were produced in house (Paul-Ehrlich-Institute (PEI), Langen, 
Germany) and HD extract, which is no longer in production, was obtained as an intermediate 
product from the manufacturers HAL (Haarlem Allergenen Laboratorium, Amsterdam, The 
Netherlands) and ALK (Allergologisk Laboratorium, Kopenhagen, Denmark). 
 
2.3.1 Processing of HD extract 
Two lyophilized intermediate products of HD extracts from different manufacturers 
(HAL/ALK) were available for our investigations. Both extracts were resuspended 1:10 in 
ammonium carbonate buffer (100 mM, pH 8.1) and then disintegrated with a sonicator to 
increase the release of antigenic material. Subsequently, the suspensions were stirred at room 
temperature (RT) overnight. Sterile filtration was performed the next day using the following 
filters (SARTORIUS AG, Göttingen, Germany): 
− Fiberglass filter (prefiltration) 
− Series connected fiberglass filter and cellulose acetate filter (Pore size: 1.2 µm) 
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− Sterile filter (Pore size: 0.22 µm) 
− The sterile suspension was prepared in 4 formulations: 
• Suspension without preservatives (native extracts) 
• Suspension with glycerole (dilution 1:1)  
• Suspension with phenole (dilution 10:1) 
• Suspension, stabilized with glycerole and phenole (dilution 5:5:1)  
The extracts without added preservatives were stored at –20°C, those containing preservatives 
at +4°C. 
Table 4: Allergenic extracts used in this study 
Allergenic source Common term Manufacturer* Batch number 
Indoor allergens 
Alternaria alternata (Alt.a.) Mold ALLERGOPHARMA 80789 30002223
Aspergillus fumigatus (Asp.f.) Mold ALLERGOPHARMA 82771 30004378
Canis familiaris (Can.f.) Dog dander ALLERGOPHARMA 60905 30003945
Cladosporium herbarum (Clad.h.) Mold ALLERGOPHARMA 64877 81629 
Dermatophagoides farinae 
(Der.f.) 
House dust 
mite ALLERGOPHARMA
 30001192 30001851
Dermatophagoides pteronyssinus 
(Der.p.) 
House dust 
mite ALLERGOPHARMA
 30000247 30004090
Felis domesticus (Fel.d.) Cat dander ALLERGOPHARMA 30001364 30001364
Homo sapiens (HD) Human dander ALK
 - 
Homo sapiens (HD) Human dander HAL
 - 
Penicillium notatum (Pen.n.) Mold ALLERGOPHARMA 72256 30000128
Outdoor allergens 
Artemisia vulgaris (Art.v.) Mugwort ALLERGOPHARMA 00010744 81944 
Betula verrucosa (Bet.v.) Birch ALLERGOPHARMA - 
Phleum pratense (Phl.p.) Timothy ALLERGOPHARMA 30002169 83492 
Triticum aestivum (Tri.a.) Wheat ALLERGOPHARMA 63298 30003753
Food allergens 
Arachis hypogaea (Ara.h.) Peanut PEI - 
Glycine max (Gly.m.) Soy PEI - 
Penaeus aztecus (Pen.a.) Shrimp PEI - 
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2.4 Determination of the protein concentration 
The determination of the protein concentration of the allergenic extracts was a necessary 
prerequisite for the comparability of further experiments and was performed using the 
commercially available kit Roti®-Nanoquant (ROTH, Karlsruhe, Germany). The kit is a 
modification of the method described by BRADFORD (BRADFORD, 1976), who introduced 
the stain Coomassie Brillant Blue G 250 to reproducibly determine the protein concentration 
of solutions. The modified method adds Roti®-Nanoquant to the aqueous solution in 
question, resulting in a color change proportional to the protein concentration. This method 
reproducibly analyzes the protein content (>200ng) of substances. 
Method: 
Six doubling dilutions of the reference serum Bovine Serum Albumin (BSA) Standard 
(PIERCE, Rockford, U.S.A) were prepared to generate a standard curve which was included 
in each plate. In a second step the samples were doubly diluted with aqua bidest. 60 µl/well of 
blanks (aqua bidest.), reference serum and samples were pipetted into a 96-well uncoated 
microtitre plate (NUNC, Roskilde, Denmark). 240µl/well of Roti®-Nanoquant reagent was 
added and the resultant color change was measured at 590/450 nm in a programmable 
automated ELISA reader (Molecular Devices SPECTRAmax® 340PC, GMI, Minnesota, 
U.S.A.). The protein concentration was calculated by the reader software.  
2.5 Determination of the biological potency of HD 
extracts 
The RBL test (HOFFMANN et al., 1999) is a murine model of the allergic type I reaction and 
is based on a rat basophil leukemia cell line which can be sensitized with murine sera or 
mouse derived monoclonal antibodies specific for the allergen. Challenge with the allergenic 
extract induces cross-linking of the antibodies and degranulation of the cells. The test is used 
for the evaluation of the biological potency of allergenic extracts. 
Method: 
The rat basophil leukemia cell subline RBL-2H3 was maintained in Eagle’s MEM with 10% 
foetal calf serum. Cells were harvested in the stationary phase and plated in 96-well tissue 
culture plates (NUNC) (105 cells/well) (18 hours at 37°C in a 5% CO2 atmosphere). Cells 
were then passively sensitized by preincubation (50µl/well) with a mouse monoclonal IgE 
antibody raised against native ALK HD (HDX, gift from PD Dr. Hoffmann), diluted 1:5 in 
MEM (1 hour). Then a three cycle wash with tyrode’s buffer (130 mM NaCl, 5 mM KCl, 1.4 
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mM CaCl2, 1 mM MgCl2, 5.6 mM glucose, 10mM 2-(4-(2-Hydroxyethyl)-1-
piperazinyl)ethanesulfonic acid (HEPES) and 0.1% BSA, pH 7.4) was performed on an 
automated plate washer (BIO-TEK Instruments, Johannesburg, South Africa). Triggering of 
the RBL cells was induced by adding 100 µl/well of a serial dilution of HD extract in tyrode’s 
buffer (one hour at 37°C in a humidified atmosphere). Each dilution was run in duplicate and 
following controls were included: 
− Negative controls:  
• Wells without allergen to measure the spontaneous release of the RBL cells 
• Wells with cells sensitized with a nonspecific mouse monoclonal antibody raised 
against birch (mP30, gift from PD Dr. Hoffmann) to determine the nonspecific 
activation of the RBL cells 
• Wells without cells to measure the intrinsic enzymatic activity of the allergenic extract 
− Positive control:  
• Total release was obtained by adding 1% Triton X-100 (SIGMA) to the tyrode buffer 
To determine the enzymatic activity of β-hexosaminidase (released from the cells), 30 µl of 
the supernatant and 50 µl of p-nitrophenyl-N-acetyl-β-D-glucosaminide (1.3 mg/ml in 0,1 M 
citric acid buffer, pH 4.5) were mixed in a separate 96-well plate (1 hour at 37°C). The 
colorimetric reaction was terminated by adding 100µl/well of a glycine solution (0.2 M, pH 
10.7) and measured at 405 nm in an automated ELISA reader. Results were expressed as 
percentage of total release minus spontaneous release. 
2.6 Determination of allergen-specific IgE in dog 
sera 
The development of a suitable protocol for detecting canine IgE and the semiquantitative 
determination of IgE levels in dog sera was performed using an NC membrane based on a 
solid phase assay in combination with a “grid-blot” device. The grid-blot, a modified version 
of a procedure developed by ALRIC et al. (ALRIC et al., 1986), is a two-piece positioning 
device consisting of an acrylic plate with multiple slots for applying reagent to NC and a 
metal plate which enables the NC to be securely (waterproof) clamped in place (see figure 1 
and 3). Rotation of the NC by 90° allows the application of a second reagent perpendicular to 
the first resulting in a cross-wise pattern on the NC (see figure 3). The grid-blot is a reliable 
and simple system, frequently used for screening antibody-allergen binding on NC (AYUSO 
et al., 1999; LANE et al., 1989) and requires only minimum amounts of allergen and 
antibody. In our study we used the grid-blot device manufactured by the IDEA SCIENTIFIC 
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COMPANY, Minneapolis, U.S.A. (figure 1). It allows parallel testing of up to 17 allergenic 
extracts with 20 patient sera on a single sheet of NC. 
Method: 
A sheet (12,5x12,5 cm) of NC membrane (0,2 µm, SCHLEICHER&SCHUELL, Dassel, 
Germany), previously soaked in Tris buffered saline (TBS, pH 7.2) for 20 minutes (min), was 
positioned on the slotted portion of the acrylic plate. A piece of parafilm and a foam pad, 
followed by the metal plate, were stacked against the back side of the NC sheet and the 
completed grid-blot was clamped securely to immobilize and seal the NC against the acrylic 
plate. The allergenic extracts, diluted in TBS (pH 7.2) to a protein content of 10 µg/ml, were 
applied to each channel in volumes of 200µl/channel. Incubation was performed overnight at 
RT on a rocking platform.  
Development of the detection protocol:  
To establish a suitable protocol for detecting canine IgE, allergens known to be common 
causative agents of allergen-specific IgE in atopic dogs were chosen (see table 4 for details on 
the allergenic extracts): 
− Native HAL HD 
− Native ALK HD 
− Der.p. 
− Der.f. 
− Phl.p. 
On the next day the channels were washed with wash buffer (TBS (pH 7.2) with 0.05% 
Tween 20) twice (10 min) and the grid-blot was disassembled. After one more wash cycle (10 
min) the NC was blocked (TBS (pH 7.2) with 0.3% Tween 20 and 1% BSA) (10 min) and cut 
into strips of 3-4 mm perpendicular to the run of the allergens (figure 2). Each strip now had 
five distinct areas, which were loaded with the allergenic extract. The strips were incubated 
with pooled serum from group I (diluted 1:10 in incubation buffer (TBS (pH 7.2) with 0.05% 
Tween 20 and 0.1% BSA)) overnight at RT. Strips were stored at –20°C and used step by step 
in the trials to develop and optimize the detection of canine IgE. The results are demonstrated 
in chapter 3. 
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Figure 1: Acrylic plate of the grid-blot 
 
 
 
 
 
                                                                              
 
                                                                = Allergenic extract 
                                                                = NC 
Figure 2: Preparation of NC strips 
 
IgE-profiling: 
After having established the detection protocol, individual IgE profiles to the allergenic 
extracts shown in table 4 were determined. The allergenic extracts were applied to the NC as 
explained above and incubated overnight at RT. On the next day the channels were washed 
with wash buffer twice (10 min) and the grid-blot was disassembled. After one more wash 
cycle (10 min) the NC was blocked (10 min), rotated by 90° and the grid-blot was 
reassembled. Channels were then perpendicular to the rows of absorbed allergenic extracts 
(figure 3). Each dog serum was diluted 1:20 in incubation buffer and 200µl were placed in 
each channel. The sera were incubated for two hours at RT. Then the channels were washed 
twice (10 min), the grid-blot was disassembled and one more wash cycle (10 min) was 
performed before continuing with immunodetection. To detect allergen-bound IgE the 
following protocol was used (antibodies were diluted in incubation buffer; three wash cycles, 
10 min each, were performed between steps): 
− Mouse α-dog IgE (SEROTEC, Raleigh, U.S.A., MCA 1895, Batch: 081100) (1:50.000, 1 
hour) 
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− Biotinylated rabbit α-mouse IgG (SIGMA, Deisenhofen, Germany Lot: 021K4862) 
(1:10.000, 1 hour) 
− Alkaline phosphatase (AP) conjugated streptavidin (CALTAG, Burlingame, U.S.A. Lot: 
20020803) (1:4.000, 30 min) 
− Visualization of antibody binding using the substrate/chromogene mixture for AP, which 
contains 5-bromo-4-chloro-indolyl-phosphate in aqueous dimethylformamide (DMF) and 
nitroblue tetrazolium in aqueous DMF solubilized in stain buffer (BIO-RAD, Hercules, 
U.S.A.) 
− Termination of the reaction with aqua dest. and air-drying of the blots overnight 
The result was a crosswise pattern (figure 3), showing each patient’s IgE profile at a glance. 
Results were evaluated semiquantitatively using a visual classification system by comparing 
the reaction to a scaled scoring system (table 5). A reaction was considered grade 1 when it 
was stronger than the background activity. 
Table 5: Scaled scoring system 
Grade of 
reaction 0 1 2 3 
Color intensity     
Evaluation Negative reaction* 
Low grade 
reaction 
Moderate 
reaction 
High grade 
reaction 
*) equal to the background activity of the allergenic extract 
 
Foam pad and 
metal plate
NC
 Allergenic extracts
Grid-blot
Patient sera
 
Figure 3: Schematic illustration of the grid-blot procedure 
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2.6.1 Statistical analysis 
The Kruskal-Wallis Test was used to assess overall significant differences of allergen-specific 
IgE levels among the four groups of dogs. If differences were found to be significant 
(P<0.05), the Dunn´s (Bonferroni) procedure was used to perform multiple pair-wise 
comparisons between the four dog groups. Statistical analyses were done using GraphPad 
Prism version 4.00 for Windows, GraphPad Software, San Diego, U.S.A., 
www.graphpad.com. 
2.7 Identification of IgE-reactive proteins for dogs 
The available HD extracts were characterized by evaluating their biological potency with the 
rat basophil leukemia cell mediator release assay (RBL test) and determining their protein 
patterns using SDS-PAGE with subsequent Coomassie staining of the proteins. IgE-reactive 
proteins for mouse and dog sera were identified by Western blotting and N-terminal 
microsequencing was performed for the relevant IgE-reactive protein for dogs. 
2.7.1 SDS-PAGE 
PAGE separates molecules from a complex mixture according to size and charge. During 
electrophoresis there is an intricate interaction of samples, gel matrix buffers and electric 
current, resulting in separate bands of individual molecules. PAGE in the presence of SDS 
separates protein molecules in complex mixtures during their migration to the anode solely 
according to size. Depending on the expected MW of the proteins different buffer systems are 
used. 
2.7.1.1 SDS-PAGE buffer system by Lämmli 
Large molecules are separated in an SDS-PAGE buffer system according to Lämmli 
(LAEMMLI, 1970). Lämmli’s buffer system is a discontinuous buffer system and 
incorporates SDS and a thiol reducing agent such as 2-mercaptoethanol in the loading buffer. 
In discontinuous buffer systems different buffer ions are present in the gel and electrode 
reservoir. By using different buffers in the gel and electrode solutions and adding a stacking 
to the resolving gel, which differ both in pore size and pH, samples are compressed into a thin 
starting band and individual proteins are finely resolved and separated. Prior to 
electrophoresis, proteins are denatured by heating them in the loading buffer. The resultant 
polypeptides take on a rodlike shape and a uniform charge to mass ratio proportional to their 
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MW. Proteins separate according to their MW, small proteins migrating faster through the 
network of pores than large ones. 
Method: 
For electrophoresis the Mini Protean® 3 cell system (BIO-RAD) was used. After cleaning the 
glass plates with alcohol, they were assembled according to the manufacturer’s instructions. A 
5 cm high 13% resolving gel (table 6) was poured, immediately overlaid with isobutanol to 
prevent oxygen contact and left to polymerize for 1 hour at RT (gel thickness: 1mm). The 
overlay solution was then rinsed completely with distilled water. Subsequently, a 1 cm high 
5% stacking gel (table 6) containing 5% Pyronin G was poured and, depending on the 
experiment, appropriate combs were inserted. The gel was left to polymerize for another hour 
at RT. Following the manufacturer’s instructions the Mini Protean® 3 cell system was 
assembled and Tris/Glycine/SDS running buffer (BIO-RAD) was filled into the chambers. 
Samples were diluted with a reducing loading buffer (Roti®Load 1, ROTH) in a ratio of 4:1 
and heated at 95°C for 5 min. After removal of the combs, HD samples were loaded into the 
wells using a pipette (20 µg protein/well). A power of 100 V was applied until the samples 
reached the resolving gel as a thin starting band, then 200 V until the samples reached the 
bottom of the resolving gel (visualised by the additive Pyronin G). MW of resolved proteins 
were calculated according to the MW marker. 
Table 6: Gel formulation: Lämmli buffer system 
Buffers and solutions Resolving gel 13% Stacking gel 5% 
Acrylamide/Bis (30%T/2.67%C) (Roth) 8.65 ml 1275 µl 
Resolving gel buffer (1.5 M Tris, pH 8.8) 5000 µl - 
Stacking gel buffer (0.5 M Tris, pH 6.8) - 1875 µl 
SDS (10%) 200 µl 75 µl 
Aqua dest. 6.050 ml 4226 µl 
N,N,N´,N´-Tetramethylethylendiamin 20 µl 10 µl 
Ammonium persulfate (10%) 90 µl 45 µl 
Pyronin G 1% - 5 µl 
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MW Markers: 
− Rainbow colored protein molecular weight marker (Low molecular weight range) 
(AMERSHAM PHARMACIA BIOTECH) 
− (2.500; 3.500; 6.500; 14.300; 20.100; 30.000; 45.000) 
− Rainbow colored protein molecular weight marker (High molecular weight range) 
(AMERSHAM PHARMACIA BIOTECH) 
− (14.300; 20.100; 30.000; 45.000; 66.000; 97.000; 220.000) 
− Low molecular weight calibration kit (AMERSHAM PHARMACIA BIOTECH) 
− (14.400; 20.100; 30.000; 45.000; 66.000; 97.000) 
− Prestained SDS-PAGE Standards, Low Range (BIO-RAD) 
2.7.1.2 SDS-PAGE buffer system by Schägger and Jagow 
The resolution of peptides below 14 kDa is not sufficient in the conventional Lämmli buffer 
system (Tris-glycine-hydrochloric acid (HCl)). SDS-PAGE electrophoresis by Schägger and 
Jagow (SCHAGGER and VON JAGOW, 1987) uses Tricine as the terminating ion, which 
allows separation of proteins in a MW range of 1 to 100 kDa.  
Method: 
The Mini Protean® 3 cell system was assembled as described above (2.7.1.1.). After pouring 
the stacking and resolving gel (table 7) with subsequent polymerization of the gels a cathode 
(0.1 M Tris, 0.1 M Tricine, 0.1% SDS) and anode buffer (0.2 M Tris/HCl, pH 8.9) were filled 
into the respective chambers. Sample processing and electrophoresis were then performed as 
described in 2.6.2.1. 
Table 7: Gel formulation: Schägger and Jagow buffer system 
Buffers and solutions Resolving gel 14% Stacking gel 5% 
Acrylamide/Bis (40% T/2.5 % C)  4.2 ml 700 µl 
Gel buffer (3 M Tris pH 8.45,  
0.3% SDS) 4.0 µl 1500 µl 
Glycerole 80% 2.0 ml - 
SDS (10%) 120 µl 60 µl 
Aqua dest. 1.8 ml 3760 µl 
N,N,N´,N´-
Tetramethylethylendiamin 6 µl 6 µl 
Ammonium persulfate (10%) 60 µl 65 µl 
Pyronin G 1% - 5 µl 
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2.7.1.3 Coomassie brillant blue staining 
Coomassie brillant blue staining is an easy way to visualise proteins separated during 
electrophoresis.  
Method: 
The gels were gently removed from the glass plates and immerged in Coomassie blue R-250 
(0.1% in 50% methanol (MeOH)) on a rocking platform (10 min). After destaining with 
several changes of 50% MeOH, 10% acetic acid, the gels were washed in deionized water on 
a rocking platform (3 wash cycles, 2 min each). The DryEase® Mini-Gel drying System 
(INVITROGEN, GmbH, Karlsruhe, Germany) was used for drying the gels. The deionized 
water was decanted, the Gel-DryTM drying solution (INVITROGEN) added and gels were 
equilibrated for 15-20 min. Rough edges of the gels were cut off and the gels were dried in an 
upright frame between two sheets of cellophane previously immerged in the Gel-DryTM 
drying solution. Gels were exposed on a LumiImager and for calculations of MW the 
Lumianalyst software (both Roche Diagnostics, Mannheim, Germany) was used. 
2.7.2 Western blotting 
Western blotting is a term used for the transfer of proteins to the surface of an immobilizing 
membrane such as NC. The molecules adsorbed to the membrane surface are freely available 
for macromolecular ligands such as antibodies. Prior to specific detection, free binding sites 
are blocked with substrates that do not influence the ensuing reaction. 
2.7.2.1 Semi-dry blotting 
Semi-dry blotting is performed between two graphite plates and sheets of filter paper soaked 
in buffer. 
Method: 
First the graphite plates of the blotter were rinsed with distilled water. 14 sheets of filter paper 
and a piece of NC were cut to fit the gel exactly and the NC and gel were equilibrated in 
anode buffer II (25 mM Tris/HCl, pH 10.4, 20% MeOH) for five min. A discontinuous buffer 
system was used. 
Assembly of the blotter: 
Six sheets of filter paper (SCHLEICHER&SCHUELL) were soaked in anode buffer I (0.3 M 
Tris/HCl, pH 10.4, 20% MeOH) and placed on the anode graphite plate (Novablot electrodes 
and Multiphor II Apparatus, PHARMACIA BIOTECH, Piscataway, U.S.A.), followed by 
2 MATERIAL AND METHODS 
 31  
three sheets of filter paper soaked in anode buffer II. The equilibrated NC membrane (0.2 µm, 
SCLEICHER&SCHUELL) and the gel were positioned on the filter papers. Five sheets of 
filter paper soaked in cathode buffer (40 mM 6-aminohexanacid, pH 7.6, 20% MeOH) 
completed the assembly. The cathode graphite plate was gently positioned and weighted with 
approximately one kg to allow electrolyte gas to be expelled. 
Blotting:  
For transfer of the proteins, 0.8 mA/cm2 were required for 45 min. After removal of the filter 
papers the NC was left to dry for 30 min and was subsequently blocked (TBS (pH 7.2) with 
0.3% Tween 20 and 1% BSA) twice for 15 min. 
2.7.2.2 Immunodetection with dog/mice/rabbit sera 
Relevant IgE-reactive proteins of allergenic extracts can be identified by probing them with 
sera from allergic patients. In our study immunodetection of HD extract was performed using 
random samples of those dog sera with grade 1 or 2 reactions to HD extract, as determined by 
grid-blotting as well as sera from mice and rabbits experimentally sensitized to HD. 
2.7.2.2.1 Immunodetection in a Microincubation Tray 
The use of a microincubation tray allows parallel incubation of NC strips from the same run 
with different sera and also the parallel use of different detection systems. 
Method: 
Using a razor blade the NC was cut into strips of three to four mm width parallel to the 
direction of the run and equilibrated in wash buffer (TBS (pH 7.2) with 0.05% Tween 20) (10 
min) prior to immunodetection. The detection protocols are described below. Antibodies were 
diluted in incubation buffer (TBS (pH 7.2) with 0.05% Tween 20 and 0.1% BSA) and each 
step was followed by three wash cycles (10 min each) in wash buffer. All detection systems 
used AP as a detection enzyme and the reaction was visualized by use of the 
substrate/chromogene mixture for AP (BIO-RAD). Blots were exposed on a LumiImager and 
for calculations of MW Lumianalyst software (both Roche Diagnostics, Mannheim, Germany) 
was used. 
Detection with dog sera: 
− Step 1: patient serum (1:20, overnight) 
− Step 2: mouse IgG α-dog IgE (SEROTEC MCA 1895, Batch: 081100) (1:50.000, 1 hour) 
− Step 3: biotinylated rabbit IgG α-mouse IgG (SIGMA, Lot: 021K4862) (1:10.000, 1 hour)  
− Step 4: streptavidin AP (CALTAG, Lot: 20020803) (1:4.000, 30 min)  
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Detection with mouse sera: 
− Step 1: Polyclonal sera (1:10, overnight) from mice sensitized to HD (from PD Dr. 
Andreas Hoffmann) 
− Step 2: AP marked rat IgG α-mouse IgE (SBA H021-RF29B) (1:1.000, 1 hour)  
Detection with rabbit sera: 
− Step 1: Polyclonal sera (1:1000, overnight) from rabbits sensitized to HD (from PD Dr. 
Andreas Hoffmann) (overnight)  
− Step 2: AP marked rat IgG α-rabbit IgG (SIGMA A 8702 016H8938) (1:20.000, 1 hour)  
2.7.2.2.2 Immunodetection with the BIO-RAD Multiscreen Device 
As an alternative to the microincubation tray method the BIO-RAD Mini-Protean II 
Multiscreen Device (BIO-RAD) can be used. The Multiscreen Device is adapted to the size of 
the SDS gel separating chamber and allows the whole blot to be clamped in place. The 
preformed channels require only minimal amounts of serum/antibodies (<150µl) for 
immunodetection. For dilutions and incubation periods: see 2.7.2.2.1. 
2.7.3 N-terminal microsequencing with polyvinylidenefluoride 
membrane 
The polyvinylidenefluoride (PVDF) membrane is a Teflon® based membrane with a high 
binding capacity and a high mechanical stability which is used for direct protein sequencing 
(MATSUDAIRA, 1987). 
Method: 
For blotting ten sheets of filter paper and a piece of PVDF membrane (BIO-RAD) were cut to 
the size of the gel. The PVDF membrane was moistened with MeOH and eqilibrated in 
transfer buffer (10 mM 3-(cyclohexylamino)-1-propanesulfonic acid (CAPS), pH 11, 10% 
MeOH) (5 min). Five MeOH equilibrated (5 min) filter papers (SCHLEICHER&SCHUELL) 
were soaked in transfer buffer and placed on the electrode, followed by the gel, PVDF 
membrane (with the smooth side facing the gel), five more transfer buffer soaked filter papers 
and the glas carbon electrode. A weight of approximately one kg was placed on top.  
Transfer: 
The transfer of the proteins to the PVDF membrane was performed in the Semi Dry Blotter 
PEGASUS (PHASE, Lübeck, Germany) with 0.8 mA/cm2  for 45 min. 
2 MATERIAL AND METHODS 
 33  
Stain: 
The PVDF membrane was immerged in Coomassie blue R-250 (0.1% in 50% MeOH) on a 
rocking platform (10 min). Destaining was performed in several changes of 50% MeOH, 
followed by three wash cycles (two min) in deionized water on a rocking platform. After 
drying, a scalpell blade was used to cut the relevant protein band from the PVDF membrane 
and was submitted for microsequencing at the “Institut für Experimentelle Biologie und 
Medizin”, Forschungsinstitut Borstel (Dr.A.Petersen). 
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3 RESULTS 
3.1 Allergenic potency of HD extracts 
The allergenic potency of HD extracts (HAL/ALK) was determined by performing the rat 
basophil leukemia cell mediator release assay (RBL test). Cells were passively sensitized by a 
specific anti-HD IgE (HDX) and a nonspecific antibody (mP30 monoclonal antibody raised 
against Bet.v.) as a negative control. The dose response curves indicating the mediator release 
induced by increasing doses of HD extract are shown in figure 4. Using a protein 
concentration of 15 µg/ml, the native extracts from HAL and ALK exhibited a mediator 
release of 60% and 30%, respectively. The nonspecific mast cell activation (using mP30) was 
similar for both extracts, with maximum mediator release values of slightly over 10%. When 
stabilizing the HD extracts with phenole and a combination of glycerole and phenole, the 
allergenic potency was markedly reduced. The sole use of glycerole had the least effect 
(figure 4).  
The observed nonspecific mast cell degranulation effects of HD extracts can either be caused 
by nonspecific interaction with any cell-bound IgE or by IgE independent mast cell triggering. 
Furthermore it must be excluded that the extract itself has an inherent mediator-like activity. 
To differentiate between these possibilities the RBL test was performed under the same 
conditions with the nonspecific antibody mP30, without sensitizing antibodies and without 
cells. For both extracts the nonspecific (without HD-IgE) colorimetric reaction remained 
unchanged whether nonspecific antibodies were employed or cells remained unsensitized 
prior to challenge with HD extract. In the experiment without cells the ALK extract induced a 
colorimetric reaction whereas the extract from HAL did not (figure 5).  
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Figure 4: Comparison of native and preserved (in glycerole, phenole and 
glycerole/phenole) HAL (black lines) and ALK (grey lines) HD extracts in a 
dose response curve: β-hexosaminidase release from RBL cells plotted 
against HD extract concentration. Specific monoclonal antibody HDX raised 
against HD (continuous lines) and nonspecific monoclonal antibody mP30 
raised against birch pollen extract (broken lines). Experiments were performed 
as duplicates. Maxima, minima and mean are shown. 
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Figure 5: Comparison of nonspecific effects in native HAL and ALK extracts in a dose 
response curve: β-hexosaminidase release from RBL cells plotted against HD 
extract concentration. Nonspecific monoclonal antibody mP30 (black lines), 
without antibody (continuous grey lines) and without cells (broken grey lines). 
Experiments were performed as duplicates. Maxima, minima and mean are 
shown. 
3.2 Determination of allergen-specific IgE in dog 
sera 
Prior to testing the dog sera for their allergen-specific IgE profile in the grid-blot, it was 
necessary to develop a suitable detection protocol for canine IgE. Based on the commercial 
availability of recently developed anti-dog IgE antibodies, several different approaches were 
compared. 
3.2.1 Allergen-specific IgE detection 
The allergen-coated and with “putatively positive” pooled dog sera (group I: “multi-source” 
atopic dogs) preincubated NC strips were tested with murine or goat anti-canine IgE 
antibodies and a corresponding AP-labeled secondary antibody. In detail, NC strips were 
incubated with the primary α-canine antibodies for one hour, followed by detection with a 
secondary anti-species antibody coupled to the enzyme AP and subsequent visualization by 
use of a substrate/chromogene mixture for AP (table 8). In all direct two step detection 
protocols the NC strips showed no colorimetric reaction.  
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Table 8: Two step detection protocols 
Primary detection 
antibody Dilution 
Secondary 
detection 
antibody 
Dilution 
Goat α-dog IgE 1:1.000 1:2.000 Mouse α-goat IgG AP 1:3.000 
Mouse α-dog IgE 1:1.000 1:2.000 Rabbit α-mouse IgG AP 1:10.000 
Mouse α-dog 
IgE+biotin 1:1.000 1:2.000 Streptavidin AP 1:3.000 
 
In a further three step experiment the sensitivity was increased by introducing a biotinylated 
detection antibody. The formation of biotin-streptavidin-AP complexes results in a significant 
signal amplification due to the multiple site binding properties of biotin and steptavidin (see 
table 9 for details on the protocol). NC strips were incubated with each antibody for one hour. 
The optimal working concentration for the secondary biotinylated anti-mouse detection 
antibody was known and therefore further titration was not performed. This detection protocol 
(table 9) was shown to be sufficiently sensitive for the detection of canine IgE. For the second 
detection system, increasing dilutions of the secondary biotinylated anti-goat detection 
antibody (table 9) revealed a gradual reduction of the colorimetric reaction. In each of these 
three step detection protocols a nonspecific activity was noted for the native HAL extract in 
the negative buffer controls, which further investigations identified as a biotin-like activity of 
the extract. 
Table 9: Enhanced detection system 
Primary 
detection 
antibody 
Dilution 
Secondary 
detection 
antibody 
Dilution Amp-lifier  
Dil-
ution 
mouse    
α-dog IgE 1:500 1:1.000 
rabbit α-
mouse 
IgG+biotin 
1: 5.000 Strept-avidin AP 1:3.000
goat        
α-dog IgE 1:1.000 
rabbit α-goat 
IgG+gly-
cerole+biotin 
1:3.000 1:10.000 1:30.000 Strept-avidin AP 1:3.000
 
Then serial dilutions of the dog serum and primary detection antibodies were tested in order to 
determine the respective optimal working concentrations. Serum was diluted 1:10 to test for 
the optimal dilutions of the primary detection antibody. Negative controls were run using 
incubation buffer instead of serum. Very high dilutions (1:128.000) of the primary detection 
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antibody still showed a colorimetric reaction in both detection systems, though the IgE 
reaction to Phl.p. became extremely weak (figure 6). The primary mouse anti-dog IgE 
antibody led to a stronger reaction compared to the goat system in all dilutions tested. A 
dilution of 1: 50.000 of mouse α dog IgE was thus selected as the optimal working 
concentration for the general protocol in later experiments.  
Similar to the above experimental design, dog serum was also titrated to an optimal dilution. 
In related studies human serum (not used in this study) is generally employed in a dilution 
between 1:7 and 1:20. Serum IgE levels in dogs are significantly higher than in human serum 
and our experiments demonstrated serum dilutions of 1:20 to be sufficient to test for allergen-
specific IgE in the dog.  
 
 
 
 
 
 
 
 
 
Figure 6: NC strips loaded with allergenic extracts displaying a decreasing colorimetric 
reaction after incubation with serial dilutions of the primary mouse IgG α-dog 
IgE antibody. 
Lane 1: 1:32.000  
Lane 2: 1:64.000 
Lane 3: 1:128.000 
Lane 4: 1:32.000 negative control (incubation buffer without primary antibody) 
Lane 5: 1:64.000 negative control (see above) 
Lane 6: 1:128.000 negative control (see above) 
Immune reagents:  
-Mouse IgG α-dog IgE (SEROTEC, MCA 1895 Lot: 081100) 
-Mouse IgG α-dog IgE + Biotin (SEROTEC, MCA 1896B Lot: 070201) 
-Goat IgG α-dog IgE (ε chain specific) (ICN, 644011 Lot: 3400E) 
-Mouse IgG α-goat IgG AP (SIGMA, 12K4822) 
-Rabbit IgG α-mouse IgG AP (SIGMA, 31K4823) 
-Streptavidin AP (CALTAG, 19020502) 
-Rabbit IgG α-mouse IgG+biotin (SIGMA, Lot: 021K4862) 
-Rabbit IgG α-goat IgG+glycerole (50%)+biotin (DIANOVA, Hamburg, Germany, Lot: 
35899) 
Native HAL HD 
 
Native ALK HD 
 
Der.f. 
 
Der.p. 
 
Phl.p. 
Lane: 1 2 3 4 5 6
3 RESULTS 
 39  
3.2.2 Frequency of allergen-specific IgE in dogs 
The grid-blot technique was used to determine the allergen-specific IgE levels in the sera of 
“multi-source” atopic dogs (group I), dogs with skin diseases other than atopy (group II), 
healthy “household” dogs (group III) and healthy kennelled beagles (group IV) against the 
allergenic extracts listed in table 4. The extracts were applied to the NC followed by 
incubation with the dog sera and IgE detection with the amplified mouse α-dog IgE protocol. 
Positive controls (P1, P2, P3) were run using dog sera demonstrating all 4 grades of reaction. 
Negative controls were run using incubation buffer and TBS buffer instead of serum and 
allergenic extracts, respectively. In addition the allergenic extract Can.f. was run as a negative 
control. Few allergenic extracts exhibited a high background activity (e.g. Pen.n., Asp.f. and 
native HAL HD), a fact taken into account when analyzing the grid-blot data. Nonspecific 
effects of sera, though rare, were also observed. Typical examples of grid-blots are shown in 
the figures 7, 8 and 9. In general, high allergen-specific IgE reactions (grade 3) to the 
common outdoor allergens included in the investigation were less frequent than to common 
indoor allergens (figure 10). 
 
 
 
 
 
 
 
 
 
 
 
 
Dog ID: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 P2 P3 B
Group: IV Contr. 
Figure 7: Grid-blot: Sera of kenneled beagle population (IV, x-axis) against selected 
allergenic extracts (y-axis). Sera of dogs demonstrating all 4 grades of 
reactions served as positive controls (P2, P3). Negative controls were 
performed using incubation buffer (B) instead of dog sera and TBS buffer 
(TBS) instead of allergenic extract. Examples of nonspecific background 
effects have been marked in frames. 
 
− Alt.a. 
− Clad.h. 
− Pen.n. 
− Asp.f. 
− Art.v. 
− Tri.a. 
− TBS 
− Can.f. 
− Phl.p. 
− Der.p. 
− Der.f. 
− Native ALK HD 
− Native HAL HD 
− Fel.d. 
− Bet.v. 
− Pen.a. 
− Gly.m. 
− Ara.h. 
− Pyronin 
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Dog ID: 19 20 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 P1 P2 P3 B
Group: IV III Contr. 
Figure 8: Grid-blot: Sera of kenneled beagle population (IV) and healthy “household” 
dogs (III, x-axis) against selected allergenic extracts (y-axis). Sera of dogs 
demonstrating all 4 grades of reactions served as positive controls (P1, P2, 
P3). Negative controls were performed using incubation buffer (B) instead of 
dog sera and TBS buffer (TBS) instead of allergenic extract. 
 
 
 
 
 
 
 
 
 
 
 
 
Dog ID: 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 P1 P2 P3 B
Group: I Contr. 
Figure 9: Grid-blot: Sera of “multi-source” atopic dogs (I, x-axis) against selected 
allergenic extracts. Sera of dogs demonstrating all 4 grades of reactions 
served as positive controls (P1, P2, P3). Negative controls were performed 
using incubation buffer (B) instead of dog sera and TBS buffer (TBS) instead 
of allergenic extract. 
 
− Clad.h. 
− Pen.n. 
− Asp.f. 
− Art.v. 
− Tri.a. 
− TBS 
− Can.f. 
− Phl.p. 
− Der.p. 
− Native ALK HD 
− Der.f. 
− Native HAL HD 
− Fel.d. 
− Bet.v. 
− Pen.a. 
− Gly.m. 
− Ara.h. 
− Pyronin 
− Alt.a. 
− Clad.h. 
− Pen.n. 
− Asp.f. 
− Art.v. 
− Tri.a. 
− TBS 
− Can.f. 
− Phl.p. 
− Der.p. 
− Der.f. 
− Native ALK HD 
− Native HAL HD 
− Fel.d. 
− Bet.v. 
− Pen.a. 
− Gly.m. 
− Ara.h. 
− Pyronin 
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Figure 10: Dominant reactivity of common indoor allergens (grey) compared to common 
outdoor allergens (black) 
3.2.2.1 Indoor allergens 
Overall statistically significant differences were demonstrated for Der.f. and Der.p.- specific 
IgE levels in all four groups of dogs (P<0.0005 in both cases). Group IV (healthy kennelled 
beagles) was shown to have significantly less Der.f.-specific IgE than the three other groups 
of dogs (I (“multi-source atopic dogs) vs. IV: P<0.001, II (dogs with skin diseases other than 
atopy) vs. IV: P<0.05, III (healthy “household” dogs) vs. IV: P<0.001).  
For Der.p. group III showed significantly more allergen-specific IgE than the other three 
groups of dogs (I vs. III: P<0.01, II vs. III: P<0.01, III vs IV: P<0.01). Comparison of the two 
house dust mites regarding their ability to induce IgE showed that Der.f. elicited a grade 3 
allergen-specific IgE response more frequently than Der.p. in three (group I, II and III) out of 
four groups of dogs (table 10 and figure 11). In group IV, the allergen-specific IgE responses 
to Der.f. and Der.p. appeared equally represented (table 10 and figure 11). Very few dogs of 
all groups tested showed no IgE-reactivity to house dust mites (≤8%). 
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Table 10: Frequency of detectable house dust mite-specific IgE by means of grid-blot 
expressed as percentage (%) in dog groups 
Group I (n=88) II (n=20) III (n=30) IV (n=40) 
             Mite 
Grade 
of reaction 
Der.f. Der.p. Der.f. Der.p. Der.f. Der.p. Der.f. Der.p. 
0 6% 8% 5% 5% 0% 3% 3% 3% 
1 18% 39% 30% 55% 13% 13% 65% 53% 
2 39% 48% 30% 40% 30% 57% 30% 45% 
3 38% 6% 35% 0% 57% 27% 3% 0% 
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I II III IV
 
Figure 11: Comparison of the frequency of grade 3 reactions in % between Der.f. and 
Der.p. 
 
Overall statistically significant differences were also revealed for the molds Pen.n. and Asp.f. 
(P<0.0005 in both cases). A statistically significant higher Pen.n.-specific IgE level was noted 
for group I when compared to group IV (P<0.001). Asp.f. only occasionally elicited a grade 3 
reaction in the grid-blot (table 11 and figure 12). In the post test, group III demonstrated 
significantly higher Asp.f.-specific IgE levels than group II and IV and group I had a 
significantly higher IgE concentration than group IV (I vs IV: P<0.01, II vs III: P<0.05, III vs 
IV: P<0.001). All four groups of dogs generated very high IgE levels to Pen.n. compared to 
Asp.f. (table 11 and figure 12).  
For both the native ALK and the native HAL HD extracts the grades of reactions were 
identical for each individual dog serum. Grade 1 reactions were common in all groups of 
dogs, whereas grade 0 and grade 2 reactions were rare. No grade 3 reactions were observed 
(table 12). The differences between the four groups of dogs were not statistically significant 
(P=0.962).  
3 RESULTS 
 43  
No statistically significant differences between the four groups of dogs were noted for the 
remaining indoor allergens Alt.a. (P=0.537), Clad.h. (P=0.285) and Fel.d. (P=0.796). 
Table 11: Frequency of detectable Pen.n. and Asp.f.-specific IgE by means of grid-blot 
expressed as percentage (%) in dog groups 
Group I (n=88) II (n=20) III (n=30) IV (n=40) 
          Mold 
Grade 
of reaction  
Pen.n. Asp.f. Pen.n. Asp.f. Pen.n. Asp.f. Pen.n. Asp.f. 
0 0% 13% 0% 10% 3% 7% 0% 28% 
1 10% 47% 15% 80% 20% 40% 35% 60% 
2 43% 39% 70% 10% 53% 47% 60% 10% 
3 47% 2% 15% 0% 23% 7% 5% 3% 
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Figure 12: Comparison of the frequency in grade 3 reactions between Pen.n. and Asp.f. 
 
Table 12:  Frequency of detectable HD-specific IgE by means of grid-blot expressed as 
 percentage (%) in dog groups 
Group 
Grade 
of reaction 
I (n=88) II (n=20) III (n=30) IV (n=40) 
0 14% 0% 0% 5% 
1 71% 100% 97% 85% 
2 15% 0% 3% 10% 
3 0% 0% 0% 0% 
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3.2.2.2 Outdoor allergens 
Analysis of the results of allergen-specific IgE levels between the four dog groups for all 
outdoor allergens revealed statistically significant differences (Phl.p.: P<0.0005, Art.v.: 
P=0.001, Bet.v.: P<0.0005 and Tri.a.: P<0.0005). For Phl.p. group III demonstrated 
significantly higher IgE levels (I vs III: P<0.001, II vs III: P<0.001, III vs IV: P<0.01) than 
the three other groups of dogs. Similarly, group III also had significantly more allergen-
specific IgE to Tri.a. than groups I and II (I vs III: P<0.001, II vs III: P<0.001). For Art.v. 
both groups III and IV had significantly more IgE than group II (II vs III: P<0.01, II vs IV: 
P<0.01), while for Bet.v. significantly higher IgE concentrations were noted for groups I and 
II vs. groups III and IV (I vs III: P<0.05, I vs IV: P<0.001, II vs III: P<0.001, II vs IV: 
P<0.001). The frequency of the grades of reaction to the outdoor allergens is demonstrated in 
figure 13. 
 
Figure 13: Scatter plots of graded IgE reactions to different outdoor allergens 
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3.2.2.3 Food allergens  
For the food allergens an overall statistically significant difference (P<0.05) was noted for 
Pen.a. (P<0.0005). The Dunn´s multiple comparison test demonstrated group I to have 
significantly higher Pen.a.-specific IgE levels than group IV (I vs IV: P<0.001). The 
frequency of the grades of reaction to Pen.a. is shown in figure 14. Results for Gly.m. 
(P=0.182) and Ara.h. (P=0.075) were not significant. 
 
 
 
 
 
 
 
 
 
 
Figure 14: Scatter plot of graded IgE reactions to Penaeus aztecus 
 
3.3 Characterization of HD extract and identification 
of an 11 kDa IgE-reactive protein for dogs 
HD extracts were characterized by determining their allergenic potency and the proteins 
present in the extracts. Furthermore, the IgE-reactive proteins of HD allergen for dogs were 
identified by probing the extract with dog sera, followed by the identification of the relevant 
protein by N-terminal microsequencing. 
3.3.1 SDS-PAGE analysis of native HD extract 
To investigate the protein patterns of the native HAL and the native ALK HD extracts, they 
were separated by SDS-PAGE with a reducing agent in a Lämmli and Schägger/Jagow gel 
formulation.  
In the Lämmli buffer system, native HD extracts were electrophoresed in 4 different protein 
concentrations and stained with Coomassie blue. In the lowest dilution a double band protein 
was visible in the low MW range (bands 3 and 4, figure 15), which was detected as a single 
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band protein in higher dilutions. Two other protein bands were detected in the medium MW 
range (bands 1 and 2, figure 15) and a further double protein band was located in the high 
MW range (not visible on the scanned gel) not strong enough for the imaging software to 
identify. Protein patterns were identical for the native HAL and the native ALK HD extracts. 
The MW of the protein bands in the native ALK HD extract marked with a “+” in figure 15 
are shown in table 13.  
A more accurate determination of the MW of the small proteins in native ALK HD extract 
was achieved by separation in a Schägger and Jagow buffer system (figure 16 and table 14). 
The protein bands in the medium MW range were calculated with approximately the same 
MW (band 3, 37 kDa and band 4, 29 kDa) as in the Lämmli buffer system. The protein band 
located in the low MW range (band 5) had an apparent MW of 9.5 kDa but a double band, as 
detected in the Lämmli buffer system (approximately 14/13kDa), was not visible. The two 
protein bands in the high MW range (band 1 and 2) were also detected and calculated to have 
a MW of approximately 58 and 51 kDa. The scanned blot (figure 16) does not show these 
bands clearly. 
 
 
 
Figure 15: Separation of native ALK HD extract by Lämmli SDS-PAGE, Coomassie blue 
staining:  
 Lane M: MW standard Amersham LMW calibration kit 
 Lane A: 20 µg protein 
 Lane B: 10 µg protein 
 Lane C: 5 µg protein 
 Lane D: 2.5 µg protein 
Marker 
 
97 kDa- 
66 kDa- 
 
45 kDa- 
 
30 kDa- 
 
20.1 kDa- 
 
14.4 kDa- 
 
Band
 
 
 
 
 
-1 
-2 
 
 
 
 
-3 
-4 
Lane:    M      A      B      C       D
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Table 13: MW of protein bands in native ALK HD extract in decreasing protein amounts 
separated by Lämmli SDS-PAGE  
A 
20 µg protein 
B 
10 µg protein 
C 
5 µg protein 
D 
2.5 µg protein 
Lanes 
 
Bands (Molecular weight in kDa) 
1 39.0 38.6 - - 
2 30.4 30.4 30  
3 13.9 14.0 13.9 13.7 
4 13.2 13.0 - - 
 
 
 
  
Figure 16: Separation of native ALK HD extract by Schägger/Jagow SDS-PAGE, 
Coomassie blue staining: 
 Lane M: marker MW standard Amersham Rainbow 755 
 Lane A: 26 µg, 
 Lane B: 13 µg protein, 
 Lane C: 7.5 µg protein, 
 Lane D: 3.75 µg protein, 
 Lane E: 1.875 µg protein 
Table 14: MW of protein bands in native ALK HD extract in decreasing protein amounts 
separated by Schägger/Jagow SDS-PAGE  
A 
26 µg protein 
B 
13 µg protein 
C 
7.5 µg protein 
D 
3.75 µg protein 
E 
1.87 µg protein
Lanes 
 
Bands 
(Molecular weight in kDa) 
1 60.4 58.3 58.3 57.2 57.2 
2 53.1 51.2 52.2 50.3 50.3 
3 38.8 38.1 37.4 36.7 35.4 
4 30.6 30.6 29.4 28.3 27.8 
5 9.5 9.5 9.5 9.3 9.5 
Marker 
 
-45 kDa 
 
-30 kDa 
 
-20.1 kDa 
 
-14.3 kDa 
 
-6.5 kDa 
 
-3.5 kDa 
-2.5 kDa 
Band 
-1 
-2 
 
 
-3 
-4 
 
 
 
-5 
 
 
Lane: M                            A     B      C     D     E 
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3.3.2 IgE-reactivity of dog sera determined by Western 
blotting  
The IgE-binding patterns of selected sera were further investigated by Western blotting using 
the native ALK HD extract. This extract was selected despite the higher biological activity of 
the native HAL HD extract demonstrated in the RBL test. This decision was based on the 
observation that the HAL extract demonstrated an inherent biotin-like activity in the 
preliminary tests (see chapter 3.2.1), raising concerns regarding the interpretation of Western 
blots employing the amplifier streptavidin in canine IgE detection.  
Random samples of those dog sera with grade 1 or 2 reactions to HD extract, as determined 
by the preliminary screening method grid-blot, were chosen for Western blotting and included 
19 sera from group I (“multi-source” atopic dogs). Dog sera from the three other groups of 
dogs were chosen as controls and included four sera from group II (dogs with skin diseases 
other than atopy), four from group III (healthy “household” dogs) and three from group IV 
(kennelled beagle dogs). The general reactivity patterns of the selected dog sera are 
summarized in table 17. 
Native ALK HD extract was separated under reducing conditions and transferred to a NC 
membrane. In the Lämmli buffer system the most prominent protein band was located in the 
low MW range (<14.3 kDa) and was detected by six sera from group I (2 are shown in figure 
17, band 5 and 6). IgE-reactivity with this protein band was not observed in the controls. 
Other IgE-reactive protein bands in the medium and high MW range (figure 17, band 1, 2, 3 
and 4) were detected by most of the other dogs tested. The calculated MW of the proteins are 
shown in table 15. 
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Figure 17: Western blot of native ALK HD extract (Lämmli) with canine sera:  
 Marker: MW standard Amersham rainbow 756 
 B: Buffer control 
 The additional “+” originate from the Lumianalyst software (Roche 
Diagnostics, Mannheim, Germany) used to calculate the MW 
Table 15: Calculated MW of IgE-reactive proteins in native ALK HD extract (Lämmli) 
I.6 I.7 I.13 I.19 I.20 I.23 II.10 II.12 III.17 III.30 IV.21
Dog ID 
 
 
 
 
 
 
 
 
 
Bands (Molecular weight in kDa) 
1 61.6 60.5 60.5 61.6 60.5 60.5 59.4 60.5 60.5 60.5 60.5 
2 52.7 51.6 51.6 52.7 51.6 51.6 49.4 51.6 51.6 51.6 50.5 
3 38.1 37.7 38.1 36.9 36.9 37.3 37.7 37.7 38.2 38.2 - 
4 29.5 29.2 29.5 29.5 29.2 28.7 28.9 28.9 28.7 28.9 28.7 
5 - 13.1 - 13.1 - - - - - - - 
6 - 12.0 - 12.2 - - - - - - - 
 
Marker 
 
220 kDa- 
 
97 kDa- 
 
66 kDa- 
 
45 kDa- 
 
 
 
30 kDa- 
 
 
 
20.1 kDa- 
 
 
14.3 kDa- 
band 5 
band 6 
band 1 
band 2 
6 7 13 19 20 23 10 12 17 30 21 B 
I II III IV  
Dog ID: 
 
Group: 
band 3 
 
band 4 
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In order to improve the resolution of the low MW proteins the buffer system by 
Schägger/Jagow was employed. In this buffer system the low MW protein bands were 
calculated with approximately 11 and 10 kDa (figure 18 and table 16). Because separation of 
low MW proteins is more accurate using the Schägger/Jagow buffer system the following 
paragraphs will refer to the 11 and 10 kDa protein.  
 
 
 
 
 
 
 
   
 
 
 
 
 
Figure 18: Western blot of native ALK HD extract (Schägger/Jagow) with canine sera:  
 Marker: MW standard Amersham rainbow 755 
 B: Buffer control 
 The additional “+” originate from the Lumianalyst software (Roche 
Diagnostics, Mannheim, Germany) used to calculate the MW 
Table 16: Calculated MW of IgE-reactive proteins in native ALK HD extract 
(Schägger/Jagow) 
I.6 I.7 I.13 I.19 I.20 I.23 II.10 II.12 III.17 III.30 IV.21 
Dog ID 
 
 
 
 
 
 
 
 
 
Bands (Molecular weight in kDa) 
5 - 11.1 - 11.7 - - - - - - - 
6 - 9.7 - 9.7 - - - - - - - 
 
 
band 5 
band 6 
Marker 
 
45 kDa- 
 
30 kDa- 
 
20.1 kDa- 
 
14.3 kDa- 
 
6.5 kDa- 
 
3.5 kDa- 
 
6 7 13 19 20 23 10 12 17 30 21 B 
I II III IV  
 
Dog ID: 
 
Group: 
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Allergens Indoor Outdoor Food
Dogs Alt
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I.4 0 2 0 2 2 1 0 1 1 3 0 2 0 1 2 2 0
I.6 1 2 0 3 2 1 0 1 1 3 0 2 2 2 2 2 1
I.7 0 0 0 0 1 1 0 2 2 1 0 1 0 1 2 2 0 I
I.8 0 0 0 2 2 0 0 1 1 1 0 1 0 1 1 1 0 I
I.9 0 0 0 0 0 0 0 1 1 1 0 1 0 1 1 3 0 I
I.11 0 1 0 1 2 1 0 1 1 2 1 1 1 2 1 2 1
I.13 0 1 0 1 2 2 0 1 1 2 0 3 2 3 3 2 1
I.19 0 1 0 1 3 1 0 2 2 2 0 0 0 1 1 1 0 I
I.20 1 2 0 1 2 2 0 1 1 3 3 2 3 3 2 2 1
I.23 1 3 0 1 3 3 0 1 1 3 0 2 0 2 1 2 0
I.31 1 1 0 2 0 2 0 1 1 2 1 2 0 3 2 2 0
I.38 2 0 0 2 3 3 0 1 1 2 0 0 0 2 1 1 0 I
I.51 0 1 0 0 2 1 0 1 1 1 0 0 0 0 1 0 0
I.55 2 2 0 1 3 2 0 2 2 2 1 0 1 0 1 2 1
I.56 1 1 0 0 2 2 0 1 1 1 1 0 0 0 1 0 0
I.58 1 2 0 1 3 2 0 2 2 3 1 0 2 1 1 1 2 I
I.60 1 1 0 1 1 2 0 1 1 2 0 0 1 0 1 1 0
I.62 2 1 0 1 2 2 0 2 2 2 1 0 1 0 1 1 1
I.75 2 1 0 1 2 1 0 1 1 2 0 0 1 0 1 1 1
II.10 1 2 0 2 2 1 0 1 1 3 1 2 2 1 1 2 1
II.12 1 1 0 1 3 2 0 1 1 2 1 0 1 1 1 1 0
II.16 1 1 0 1 3 2 0 1 1 2 1 1 2 2 1 1 1
II.17 1 1 0 1 2 1 0 1 1 3 1 1 2 1 1 1 2
III.16 1 2 0 1 3 2 0 1 1 2 1 0 1 1 1 1 1
III.17 1 2 0 1 2 2 0 1 1 2 1 0 2 1 1 1 2
III.25 1 0 0 1 1 0 0 1 1 2 0 0 0 0 0 1 0
III.30 1 2 0 3 1 1 0 1 1 3 1 0 1 1 2 2 1
IV.21 1 0 0 1 1 2 0 1 1 1 2 1 2 1 1 1 1
IV.22 1 1 0 1 1 1 0 1 1 1 0 0 1 1 1 0 1
IV.23 1 1 0 1 1 1 0 1 1 1 1 0 1 1 1 1 1
G
ro
up
 I
G
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up
 II
G
ro
up
 II
I
G
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up
 
IV
Table 17: Reactivity patterns (grid-blot) of dog sera included in the Western blots: the 
allergenic extracts are shown on the x-axis and dog sera on the y-axis. Those 
sera with IgE-reactivity to the 11 kDa protein are marked with an arrow 
 
3.3.3 Identification of the 11 kDa HD IgE-reactive protein as 
human cystatin A 
The N-terminal sequence of the 11 and 10 kDa protein was determined by resolving HD 
extract in a 12% SDS-PAGE gel with subsequent transfer to a PVDF membrane. After 
visualizing the proteins with Coomassie blue, the band was excised and submitted for N-
terminal sequence analysis at the Institut für Experimentelle Biologie und Medizin, 
Forschungsinstitut Borstel, Germany, Laboratory of Dr. Arndt Petersson. At the N-terminus 
the following sequence was obtained S-P-G-G-L-S-E-A-K. Database-Alignment (SwissProt: 
Accession number: P01040) showed 78% consensus of the N-terminally sequenced 11 kDa 
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protein to the N-terminal end of human cystatin A. Further investigations (SwissProt) showed 
human cystatin A to be a highly conserved protein (figure 19). N-terminal sequence analysis 
of the 10 kDa protein was only partially possible. To a certain degree the determined amino 
acids agreed with the by four amino acids abbreviated cystatin A. As further proof, binding of 
a monoclonal antibody against human cystatin with the questionable 11 kDa protein was 
tested. The very clear binding of the anti-cystatin to the respective band was interpreted as a 
second confirmation that the 11 kDa protein in HD extracts identified by canine IgE is 
identical to human cystatin A (figure 20). 
 
 
Figure 19: Alignment of mammalian cystatins in comparison to the first 9 aminoacids of 
the 11kDa protein determined by N-terminal sequencing (top row) 
3.3.4 Dog/mouse comparison of IgE-reactivity determined 
by Western blotting 
In many instances sera from the subjects to be investigated - dog sera in this case - are sparse, 
and therefore valuable, and replacing them by sera from artificially sensitized laboratory 
animals is of benefit. Therefore the IgE-reactive patterns to native ALK HD extract of the 
different mammalian species were compared in a Western blot (figure 20). The murine 
antibodies were raised by immunisation of BALB/c mice with HD extracts and the rabbit 
hyperimmune serum was also obtained by sensitizing rabbits with HD extract. All three 
species recognized the 11 kDa protein human cystatin A; as well as the protein in the medium 
MW range, at approximately 30 kDa, thus arguing for the possible use of sera from laboratory 
animals instead of dog sera in future studies. Serum from a non-sensitized mouse, non-
sensitized rabbit and a dog from the kennelled beagle population were run as negative 
controls and a monoclonal antibody raised against human cystatin A was run as a positive 
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control. The dog serum used as a negative control recognized the 30 kDa medium MW 
protein as well as two other bands located in the medium MW range, though not the 11 kDa 
protein. A further strip of NC was run with a buffer control for each detection system. 
 
Figure 20: Western blot of native ALK HD extract (Lämmli) with canine, murine and rabbit 
sera; 
 Lane M: marker MW standard Amersham Rainbow 756 
 Lane A: polyclonal mouse serum sensitized against HD 
 Lane B: polyclonal rabbit serum sensitized against HD 
 Lane C: Dog serum (I.38) 
 Lane D: monoclonal α-cystatin antibody 
 Lane E: negative control: serum from a non-sensitized mouse 
 Lane F: negative control: serum from a non-sensitized rabbit 
 Lane G: Dog serum (IV.23) 
 Lane H: negative buffer control detection system mouse  
 Lane I:  negative buffer control detection system rabbit 
 Lane J: negative buffer control detection system dog 
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4 DISCUSSION 
At least two reasons argue for the increasing importance of indoor allergens as causative 
agents of allergy: Firstly, due to modern living and working habits the challenge of the 
individual with common indoor proteins has risen over the past decades; secondly, many 
patients today display allergic symptoms throughout the year. Typical indoor allergens 
identified by clinical experience in human allergology, are house dust mites, molds and 
epidermals originating from pets. These allergens have become equally or possibly even more 
important than outdoor allergens such as grass or birch pollens. In general dogs or other pets 
living mainly indoors are challenged with the same variety of indoor allergens as human 
occupants. However, one exception is epidermals originating from human beings themselves. 
It is a matter of common knowledge that mammalian proteins in particular are among the 
most potent allergens for human beings. Conversely human epithelial proteins, also allergens 
of mammalian origin, may cause allergic disease in dogs. So far, human epidermals or HD 
extracts have been poorly characterized as an allergen source. In order to perform further 
studies regarding the sensitization of dogs to human epidermals and proteins, a well 
characterized HD extract is essential. In this study the biological potency and protein patterns 
of two available HD extracts were determined by the recently developed RBL cell mediator 
release assay and SDS-PAGE, respectively. These characterized HD extracts were then 
included in a representative panel of allergens used to screen four typical dog populations for 
their allergen-specific IgE profiles and HD-specific IgE levels in particular. Dog sera 
identified as having the highest allergen-specific IgE concentrations to HD then served as 
probes for the identification of IgE-reactive proteins and the elucidation of their biological 
nature.  
4.1 Characterization of HD extract: a basic requirement 
for the qualified diagnosis of HD-related atopy 
Any qualified specific allergy treatment, i.e. both desensitization and allergen avoidance 
measures, requires the identification of the allergenic source responsible for evoking clinical 
symptoms. The application of allergenic extracts in the diagnosis and later in immunotherapy 
require a special degree of standardization. To date, nearly all clinically relevant allergenic 
extracts are available in standardized quality appropriate for application in human beings. 
This however, is the result of long years of effort in this field. Standardization measures 
include the characterization of allergenic extracts, i.e. the determination of allergenic proteins 
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and the evaluation of allergenic potency. The most essential tools for these procedures are 
sera from patients confirmedly suffering an allergy from the respective allergen source. The 
majority of allergenic extracts standardized for use in human beings are most likely also 
suitable as test allergens in dogs. The exceptions however, as mentioned above, are extracts 
from HD which cannot be characterized by human sera. Therefore a main focus of this study 
was the characterization of HD allergenic extract, a matter requiring an unusual approach for 
following reasons. Without HD extracts proven to be sufficiently potent or ideally, 
standardized test allergens, canine patients hypersensitive to human beings cannot be 
identified. Conversely standardized HD extracts cannot be produced without sera from 
patients which are confirmedly sensitive to HD. As a way out of this dilemma we employed 
the RBL test, a model using serum from artificially sensitized Balb/c mice to determine the 
biological potency of allergenic extracts. This method was originally used for the 
experimental biological standardization of cat, dog and horse dander extracts independent of 
humans (HOFFMANN, 1999). For this study, mice were artificially sensitized to HD extracts. 
For practical reasons however the sensitization of the RBL cells with murine sera was 
replaced by sensitization with monoclonal HD-specific IgE antibodies derived from spleen 
cells of the above mentioned mice. The RBL test allowed the thorough investigation of two 
intermediate products of HD extracts regarding their biological potency.  
Though both native extracts demonstrated high allergenic activity in the RBL test, both also, 
to a lesser extent, elicited nonspecific degranulation of the RBL cells. On further investigation 
it was found that the nonspecific effects exhibited by the native ALK HD extract were due to 
a β-hexosaminidase-like activity of the extract itself. In contrast, the nonspecific effects of the 
native HD extract from HAL were due to nonspecific activation of the RBL cells. The 
phenole and phenole/glycerole preserved extracts were found to be far less potent; the sole 
use of glycerole had the least effect on the deterioration of the allergenic properties. Our 
results support the findings of a study published in 1981 (NELSON) which demonstrated 
phenole to be markedly inferior to glycerole.  
By SDS-PAGE and Coomassie staining the protein patterns for both extracts were shown to 
be identical. Protein bands were detected at MW of approximately 58, 51, 37, 29 and 9.5 kDa 
in the Schägger and Jagow buffer system. In the Lämmli buffer system the high MW proteins 
were not strong enough for the imaging software to calculate. The remaining proteins had 
slightly different MW at approximately 39 kDa and 30 kDa and the low MW protein was 
demonstrated as a double protein band at approximately 14 kDa and 13 kDa. The high and 
low MW proteins correspond well with the MW of proteins in a HD extract calculated by a 
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study group in 1988 (YU et al., 1988). In this study an aqueous HD extract obtained by 
combing the scalp of two healthy adults, was divided into four fractions by high-speed gel 
filtration chromatography and subsequent investigation of the fractions by SDS-PAGE. 
Fraction 2 had two major protein bands with MW of 10 and 13 kDa, respectively and fraction 
1 gave two major protein bands at 59 and 52 kDa. The remaining two fractions scarcely 
contained substances that were stainable.  
SDS-PAGE and RBL test results demonstrated that both HD extracts were suitable for the 
planned immunological experiments, i.e. IgE-profiling and identification of IgE-reactive 
proteins via Western blotting.  
4.2 IgE-profiling in four selected dog groups 
Canine sera were screened for their IgE-reactivity with a panel of allergenic extracts in the 
NC-based solid phase assay “grid-blot”. Using this technique a detailed investigation of the 
allergen-specific IgE profile for a panel of indoor, outdoor and food allergens was performed 
in potentially atopic dogs (group I), dogs with skin diseases other than atopy (group II) and 
healthy individuals, including “household” dogs (group III) and kennelled beagle dogs (group 
IV). Varying IgE profiles of individual dogs were successfully demonstrated with this 
method, suggesting the detection protocol for canine IgE to be sufficiently sensitive. 
However, in light of the problems encountered with the specificity of serological IgE methods 
and the lack of a gold standard in this study, the results obtained by the grid-blot and 
discussed in detail below must be interpreted with caution. In this study the serological 
determination of IgE levels by grid-blotting should primarily be regarded as a 
semiquantitative screening method for the presence of allergen-specific IgE and a prerequisite 
for the identification of HD-specific IgE-reactive proteins for dogs.  
Using the grid-blot procedure nonspecific reactions to certain allergens, e.g. Pen.n., Asp.f. and 
native HAL HD, were an occasional occurrence; these phenomenona are sometimes observed 
in this type of assay and can be explained by a residual binding activity of biotin-labelled 
polyclonal rabbit α-mouse IgG antibody. Sensitization of the rabbits to other antigens in their 
environment other than the desired is probable and despite purification by affinity 
chromatography a residual binding activity to the corresponding allergenic extracts coated on 
the NC is possible. A further possible reason for nonspecific reactions is a biotin-like activity 
of allergenic extracts as was observed for the HD extract from HAL (data not shown). 
Nonspecific reactions of individual sera were also observed, a phenomenon caused by a high 
nonspecific binding capacity of the sera to the matrix used. These nonspecific reactions did 
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not impede the evaluation of the results as the background activity was taken into account 
when grading the reactions. 
The statistical evaluation of the grid-blot results revealed partially significant differences 
between the groups of dogs for the indoor allergens house dust mites and molds.  
In general both mites, though Der.f. more than Der.p., elicited very high serum IgE responses 
in all four groups of dogs, i.e. very few non-reactors and many grade III reactors. This finding 
supports the well-known fact that house dust mites and Der.f. in particular (PRELAUD, 2002) 
are among the most common indoor allergens to cause positive reactions in intradermal and 
serologic allergen-specific IgE testing in dogs (BENSIGNOR and CARLOTTI, 2002; 
CARLOTTI and COSTARGENT, 1994; LIAN and HALLIWELL, 1998; PRELAUD, 2002; 
STURE et al., 1995; VOLLSET, 1985). One explanation for the sensitization rate are the 
conditions in which pets are kept, moist bedding for example, resulting in a high exposure of 
“indoor” dogs to mite allergens (BENSIGNOR and CARLOTTI, 2002). A further possible 
reason for the high prevalence of IgE to house dust mites was suggested in 1995 (HEWITT et 
al.), where Der p 1 was shown to selectively cleave the low affinity IgE Fc receptor (CD23) 
from the surface of human B lymphocytes. The authors hypothesized that the loss of CD23 
may promote and enhance the IgE immune response by ablating an important feedback 
inhibitory mechanism that normally limits IgE synthesis. Whether this mechanism is relevant 
for dogs remains to be proven. Dogs are more frequently sensitized to Der.f. than to Der.p., an 
observation which was once more confirmed in this study. This phenomenon was explained 
by a recent investigation performed by RANDALL et al. (2003) which quantified house dust 
mites and their allergens in the microenvironment of dogs. Whereas Der f 1 was detected in 
100% of the homes, Der p 1 was detected in only 74% of the homes and Der.f. mites were 
also found more commonly and in a higher density than Der.p. mites. Group IV, kept in a 
virtually allergen-free environment had significantly less serum IgE to Der.f. than the three 
remaining dog groups, indicating the production of Der.f.-specific IgE to be primarily linked 
to exposition. For Der.p. group III showed significantly more IgE in serum than the other 
three groups of dogs. This might implicate the presence of heterogenous IgE in group III. 
Apart from the above mentioned statistically significant differences, surprisingly, serum IgE 
levels against mites in group I did not differ from the three other groups of dogs, a fact 
supporting the concept that alternative pathways may be responsible for clinical 
hypersensitivity responses, e.g. mast cell hyperexcitability. 
The group of molds was comprised of four frequently found in indoor dwellings including 
Pen.n., Asp.f., Alt.a. and Clad.h. (OPPERMANN et al., 2001). Overall statistically significant 
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differences were revealed for Pen.n. and Asp.f. A comparison of Pen.n.- and Asp.f.-specific 
IgE levels demonstrated that high Pen.n.-IgE levels were more frequent than high Asp.f.-IgE 
levels. This finding is in accordance with a study performed in 1989 (KLEINBECK et al., 
1989), in which serum IgE antibodies against Pen.n. were found in 100% of the atopic dog 
sera and Asp.f.-IgE were present in only 81% of the cases. These results suggest a higher 
concentration of Pen.n. than Asp.f. in homes in general. Alternatively, a higher contamination 
of the dog’s microenvironment with Pen.n., similar to the situation for the house dust mite 
Der.f. (RANDALL et al., 2003) is possible. Further studies of the mold species found in the 
dog’s microenvironment, i.e. dog beds etc. are required to confirm this theory. A statistically 
significant higher serum concentration of Pen.n.-specific IgE was noted for group I when 
compared to group IV, a finding which can be explained by a very low exposition of the 
kennelled dogs to molds due to housing on concrete floors and regular cleaning programs 
ensuring a relatively low mold contamination of the environment. The same can be stated for 
Asp.f. Group IV had significantly lower allergen-specific IgE levels than group III and 
group I.  
To complete the panel of the most important indoor allergens mammalian proteins were also 
tested in the grid-blot. In humans, animal allergens are common causes of both acute and 
chronic allergic disease (CHAPMAN and WOOD, 2001). The most important animal 
allergens are derived from mammals, which secrete or excrete allergens into the environment. 
Allergens originating from cats and dogs are good examples for common causes of asthma 
and allergic rhinitis in man. Thus, it is only reasonable that the human being also produces 
allergens to which other species may develop a hypersensitivity reaction. We tested two 
suitable HD extracts in the grid-blot assay in order to determine the frequency of serum IgE 
against HD in the dog population and also to identify dogs with HD-specific IgE for further 
immunological experiments. Remarkably, in contrast to other studies (BOND et al., 1994; 
WILLEMSE et al., 1985), only few dogs had high HD-specific IgE concentrations in serum. 
Whereas grade 1 reactions were a common finding none of the dogs showed a grade 3 
reaction and grade 2 reactions were also rarely observed. 
There are several possible reasons for these conflicting results. Firstly, one might assume that 
our assay was not sufficiently sensitive. However, the possibility of inadequate extract 
potency was ruled out by evaluation in the RBL test prior to grid-blotting. The general test 
sensitivity was also sufficient since the other indoor and outdoor allergens, run in every grid-
blot assay, served as intraassay controls of the method and the detection protocol. Conversely 
the in vitro assays in the previously mentioned studies perhaps may have been too sensitive, 
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possibly by a lack of specificity of the detecting antibodies. Early anti-IgE antibodies, 
especially polyclonal ones tended to detect allergen-specific IgG in addition to allergen-
specific IgE, an error potentially causing false positive reactions. In studies surveying skin test 
reactivity nonspecific reactions of patients to the skin test antigens used may have elicited 
false positive test results. Despite these rather simple explanations the question appears to be 
more complex: If mammalian proteins are such important allergens, why do dogs show so few 
positive reactions? The most plausible explanation for the low sensitization rate to HD in our 
source of patients is a low exposure of dogs to HD in their environment. Low indoor 
concentrations of HD can be explained by the high hygienic standards in the industrialized 
countries, such as most people showering on a daily basis and changing garments regularly. 
This is in accordance with the high frequency of low levels of HD-specific IgE (grade 1) in 
dog sera, verifying that dogs are in contact with low concentrations of the human epithelial 
allergens. Grade 0 reactions were rare, though surprisingly, group I had 14% non-reactors. 
Part of these non-reactors might truly not have been sensitized to HD, though the high 
percentage seems improbable in the “multi-source” atopic dog population. One possible 
reason is the presence of cell-bound IgE, which does not circulate and therefore cannot be 
detected. Another possibility, which we are unable to differentiate from the above mentioned, 
is the involvement of a cell-mediated immune reaction. Remarkably, group IV had a high 
percentage of grade 2 reactors. There are several possible explanations for this finding. The 
environment might have been highly contaminated with HD, though higher levels of HD in a 
kennel environment than in a household situation seem improbable. A further possibility is 
cross-reactivity of HD with environmental or food allergens not included in our panel. 
High allergen-specific IgE reactions (grade 3) to the common outdoor allergens included in 
the investigation were less frequent than to common indoor allergens. Both dogs and humans 
spend a greater proportion of their lives indoors and are in contact with a larger proportion of 
the air from the indoor environment (POPE et al., 1993), whereas contact with outdoor 
allergens is limited to certain seasons and is mostly restricted to a few hours a day. Because 
IgE production is correlated with allergen exposure, it is a logical consequence that 
sensitization to indoor allergens is a more common finding. A more detailed analysis of the 
results revealed statistically significant differences between the four groups of dogs for all 
outdoor allergens tested. For Phl.p. group III demonstrated significantly higher serum IgE 
levels than the three other groups of dogs. Similarly, group III also had significantly more 
allergen-specific IgE to Tri.a. than groups I and II. For Art.v. both groups III and IV had 
significantly more serum IgE than group II, while for Bet.v. groups I and II had significantly 
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more IgE than groups III and IV. The results obtained for Phl.p., Tri.a. and Art.v. implicate 
the presence of protective heterogenous IgE, i.e. IgE which does not lead to clinical atopy and 
protects the patient from developing a hypersensitivity reaction. This was not the case for 
Bet.v.-specific IgE, which correlated with clinical atopy and skin disease.  
A third group of test allergens was comprised of the food allergens shrimp, peanut and soy 
bean. An overall statistically significant difference was only noted for the shrimp allergen 
Pen.a. Group I was shown to have significantly higher serum IgE levels than group IV. High 
IgE levels to Pen.a. can either be related to a “real” IgE response to shrimp allergen or 
possibly be the consequence of cross-reactive antibodies. 
The analysis of the IgE levels to the allergens Alt.a., Clad.h., Fel.d., Gly.m. and Ara.h. 
revealed no statistically significant differences between the 4 groups of dogs.  
Considering that IgE is thought to play the central role in atopy, this finding is surprising. 
However, a detailed investigation of the available literature in the recent past revealed that 
other studies demonstrated similar results when comparing allergen-specific IgE levels of 
atopic and healthy dogs (LIAN and HALLIWELL, 1998) indicating that high levels of 
allergen-specific IgE in serum are not solely responsible for the development of atopic 
disease. The importance of IgE in the pathogenesis of atopy has always been controversial 
and some authors suggest IgE to represent merely an epiphenomenon (HOLDEN and 
PARISH W.E., 1998). Though if IgE does play a major role in the pathogenesis of atopy, 
other explanations for the elevated allergen-specific IgE levels found in healthy individuals in 
this (healthy “household” and kenneled dogs) and in other studies are called for. The presence 
of heterogenous IgE, IgE+ and IgE-, is a theory being discussed in human allergology 
(MACDONALD et al., 1987). IgE+ and IgE- differ in their ability to mediate histamine 
release through interaction with certain co-factors, termed histamine releasing factors (HRF). 
In 1995 (MACDONALD et al.) a specific HRF, that is synergistic with IgE from IgE+ 
donors, was identified and cloned. In veterinary medicine this theory received support from 
two studies. Jackson et al. (1996) found that leukocytes from atopic dogs had a greater 
tendency to release histamine than those from normal or artificially sensitized dogs 
independent of total or allergen-specific serum IgE levels. Peng et al. (PENG et al., 1997) 
demonstrated two differing biologically active fractions of polyclonal dog IgE, which further 
supported the possibility of a relationship between heterogenous IgEs and the allergic 
response in the dog. A second theory suggests differences in mediator releasability of mast 
cells between atopic and healthy individuals (HALLIWELL and DEBOER, 2001). In 1996 
(DE MORA et al.) a study group demonstrated enhanced mast cell releasability in atopic skin 
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compared to normal skin, suggesting that up-regulatory factors might be produced in canine 
AD to prime mast cells for subsequent allergen challenge. One of the mediators possibly 
responsible for the inherent mast cell hyperexcitability observed in canine AD is dermal stem 
cell factor, a mediator whose dermal secretion was suggested to potentiate histamine release 
following IgE receptor cross-linking (HAMMERBERG et al., 2001). A third concept suggests 
anti-IgE autoantibodies to be involved in the pathogenesis and modulation of IgE-mediated 
disease (DE WECK and STADLER, 1993; KOIKE et al., 1989). It is important to remember 
that all these concepts do not preclude one another but rather might all be intricately involved 
in the complex pathogenesis of IgE-mediated hypersensitivity reactions.  
IgE assays are only of limited value as a specific tool in the diagnosis of atopy and until 
studies have examined the role of heterogenous IgE in clinical atopy, allergen-specific IgE 
assays clearly should be interpreted with caution. Furthermore, studies must also focus on 
other aspects of the pathogenesis of hypersensitivity, i.e. mast cell hyperexcitability in atopic 
dogs and the possible presence of heterogenous IgE, to further elucidate the complex and 
intricate pathogenesis of type I hypersensitivity.  
4.3 Identification of cystatin A as an IgE-reactive protein 
of HD extract for dogs 
The systematic investigation of HD extracts and the successful identification of IgE reactors 
in the dog population probably suffering from this allergen source allowed an approach going 
beyond the original goal: The identification of an IgE-reactive protein potentially of relevance 
for the development of clinical HD-related hypersensitivity in dogs. Sera with grade 1 and 2 
reactions were used as probes for the identification of IgE-binding proteins of HD extract in 
Western blots. The HD extract from ALK was used for this purpose to avoid the nonspecific 
biotin-like effects of the HAL extract. Few dogs of the “multi-source” atopic dog population 
(n=6) showed a strong reaction with low MW proteins (approximately 10 and 11 kDa). In 
some blots this protein was only visible as a single band with an apparent MW of 11 kDa. In 
contrast, most of the dogs tested in Western blots throughout all four groups demonstrated 
less prominent IgE-reactive protein bands with apparent MW of 30, 38, 51 kDa and 60 kDa. 
Given the fact that most dogs displayed minor IgE-reactivity to the latter proteins the mostly 
low allergen-specific IgE-reactivity scores obtained during grid blotting (<1) can be 
explained. Because reactivity to the 51/60 and 30/38 kDa proteins were also found in a high 
percentage of the healthy dog population, clinical relevance seemed improbable and these 
proteins were not investigated further. In contrast, only individuals from the “multi-source” 
4 DISCUSSION 
 62  
atopic group demonstrated strong IgE-reactivity to the 11 and 10 kDa protein, making them 
more likely to be involved in clinical atopy. Therefore these two proteins were further 
investigated by N-terminal microsequencing. Investigation in a database (SwissProt: 
Accession number: P01040) showed 78% consensus of the N-terminal sequenced 11 kDa 
protein to the N-terminal end of human cystatin A (Stefin A), a cysteine protease inhibitor. 
Human cystatin A consists of 98 amino acids and has a calculated MW of 11, 006 kDa which 
is in agreement with the MW detected by the canine serum. The amino acids determined 
showed a certain agreement with the by four amino acids abbreviated cystatin A, suggesting a 
fragment of cystatin A. These findings indicate that fragmentation of cystatin A can occur 
under certain circumstances. Further confirmation was obtained by employing a monoclonal 
α-cystatin antibody, which bound to the low MW protein. Inhibition of the IgE-binding 
reactivity of dog serum by means of a monoclonal antibody against cystatin A showed a slight 
inhibition of the reaction (data not shown). This is to be expected because a monoclonal 
antibody detects only one epitope on the relevant protein and consequentially might not be 
able to saturate all binding regions detected by the dog serum.  
Cystatins are cysteine protease inhibitors whose main physiological function is believed to be 
protection of the host from the harmful effects of free cysteine proteases by rapidly trapping 
these enzymes in tight complexes. The cystatin superfamily is divided into three subgroups, 
including the type I cystatins (stefins), which are mainly intracellular, type 2 cystatins, and 
kininogens. Type I cystatins are small acidic proteins consisting of about 100 aminoacid 
residues and lacking disulfide bonds. Human cystatin A functions as a cysteine protease 
inhibitor, forming tight complexes with papain and the cathepsins B, H and L. The primary 
structure of cystatin A was first determined in 1983 (MACHLEIDT et al., 1983). The protein 
is one of the precursor proteins of the cornified cell envelope in keratinocytes and plays a role 
in epidermal development and maintenance (TAKAHASHI et al., 2001).  
Cysteine protease inhibitors have already been established as allergens. In 2001 (ICHIKAWA 
et al., 2001) cystatin as an allergenic component of cat dander was identified by screening a 
cat cDNA library using human IgE antibodies to cat dander and subsequent sequencing and 
expression of selected clones. The cat cystatin clone contained the conserved cysteine 
protease motif and two of three lipocalin motifs. Recombinant cystatin was produced in 
Escherichia coli cells and purified as an 11 kDa protein. The newly identified allergen was 
termed Fel d 3. Cysteine protease inhibitors are highly conserved proteins as demonstrated by 
the alignment in chapter 3.3.3. All species have them and bovine, porcine, murine and feline 
cystatin A are extremely similar to each other. Sequence homology searches of feline cystatin 
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revealed a high degree of identity with bovine and human cystatin A, 79% and 75%, 
respectively. The fact that all species have highly conserved cysteine protease inhibitors 
makes their allergenic properties very remarkable. This leads to a speculative question. How 
can an organism be allergic to a protein that it harbours itself? In the case of lipocalins, a 
family of extracellular proteins that most allergens of the mammalian origin belong to, it has 
been proposed (MANTYJARVI et al., 2000) that the immune response against the lipocalin 
allergens which are structurally related to endogenous lipocalins might be the pathway to 
allergy in genetically predisposed individuals. The same might well apply to other allergens 
with homologous endogenous counterparts such as the cystatins. 
In summary we identified the 11 kDa molecule cystatin A, a protein capable of eliciting an 
IgE reaction in dogs. Further studies are necessary to determine the clinical relevance for 
human cystatin A in canine atopy by the use of a purified preparation of the 11 kDa protein in 
an intradermal test in atopic individuals and clinically healthy controls.  
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5 SUMMARY 
Background – perennial indoor allergens, among them house dust mites and molds are 
known to be important inducers of IgE-mediated hypersensitivity reactions in dogs. Human 
dander (HD), an important constituent of house dust may also be a major cause of atopic 
disease in dogs. So far, HD has been poorly characterized as an allergenic source and the role 
HD plays in veterinary medicine is unclear. 
Objective – the aims of this study were to characterize two available HD extracts, thus 
completing a representative panel of allergens used to screen four typical dog populations for 
their allergen-specific IgE profiles. A further aim of this study was the identification of 
specific IgE-binding proteins in HD extract and the elucidation of their biological nature. 
Material and methods – the HD extracts were investigated regarding their biological 
potency and protein patterns using a recently developed cell mediator release assay (RBL-
test) and SDS-PAGE, respectively. Both extracts were then included in a panel of common 
indoor (n=8), outdoor (n=4) and food (n=3) allergens to examine “multi-source” atopic dogs 
(n=88), dogs with skin diseases other than atopy (n=20), healthy “household” dogs (n=30) 
and kenneled beagle dogs (n=40) regarding their serologic allergen-specific IgE profiles using 
a solid-phase assay based on the “grid-blot” device. The reactions were graded 
semiquantitively in ascending order (0,1,2,3) according to the concentration of allergen-
specific serum IgE. The identification of IgE-binding proteins in HD extract was performed 
by Western blot using dog sera demonstrating postitive reactions to HD (grade 1 and 2) as 
probes.  
Results – statistically significant differences of serum IgE levels between the four groups 
were demonstrated for nine of the allergens tested in the grid-blot though these differences 
failed to follow a specific pattern. In general the sensitization rate to indoor allergens was 
higher than to outdoor allergens in all groups of dogs. For HD, grade 1 reactions were 
common in all groups of dogs, grade 3 reactions were not seen in any of the dogs tested and 
grade 2 reactions were also an infrequent finding. Six sera from the “multi-source” atopic 
dogs demonstrated IgE-binding to a protein with an apparent molecular weight of 11 kDa, 
which N-terminal microsequencing identified as human cystatin A. Control sera selected from 
the three other groups of dogs did not demonstrate IgE-reactivity with this protein. 
Conclusions – semiquantitatively determined high allergen-specific IgE levels do not appear 
to be correlated with the development of clinical hypersensitivity in dogs and may simply 
reflect contact with the respective allergen source. Overall high HD-specific serum IgE levels 
were an infrequent finding in the canine population investigated in this study; however, in 
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atopic individuals, elevated HD-specific IgE can be consistent with IgE-reactivity to the 
cysteine protease inhibitor human cystatin A. Thus, this antigen appears to be of relevance for 
the development of clinical HD-related hypersensitivity in dogs.  
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6 ZUSAMMENFASSUNG 
Hintergrund – Perenniale Allergene, wie z.B. Hausstaubmilben und Schimmelpilze gelten 
als verbreitete Auslöser der IgE-vermittelten Hypersensitivität beim Hund. Menschliche 
Hautschuppen oder Haarbälge, die meist mit Talg, Schweiß oder Speichel verunreinigt sind, 
und unter dem englischen Fachterminus „Human dander“ (HD) zusammengefasst werden, 
bilden einen proteinreichen Bestandteil im Hausstaub, welcher ebenfalls eine zentrale Rolle 
bei der Entwicklung atopischer Erkrankungen des Hundes spielen könnte. Bis jetzt ist HD als 
Allergenquelle nicht hinreichend charakterisiert worden und die Bedeutung dieses Allergens 
wird in der Veterinärmedizin z.Zt. widersprüchlich beurteilt. 
Ziel der Studie – Ziele dieser Studie waren die Charakterisierung von HD Extrakten zweier 
Hersteller, sowie das Zusammenstellen von repräsentativen Allergenen zur Untersuchung vier 
typischer Hundepopulationen hinsichtlich ihres allergenspezifischen IgE Profils. Ein weiteres 
Ziel bestand in der Identifizierung IgE-reaktiver Proteine in HD Extrakten. 
Material und Methoden – die HD Extrakte wurden hinsichtlich ihrer biologischen 
Wirksamkeit und ihres Proteinprofils mittels eines neuen Mediatorfreisetzungstests (RBL-
Test) bzw. SDS-PAGE untersucht. Beide Extrakte wurden ergänzend in eine 
Zusammenstellung von „Indoor-“ (n=8), „Outdoor-“ (n=4) und Futtermittel- (n=3) Allergenen 
aufgenommen, die zur Erstellung eines serologischen IgE-Profils bei potentiell atopischen 
Hunden (n=88), Hunden mit Hauterkrankungen anderer Genese (n=20), gesunden im 
Haushalt gehaltenen Hunden (n=30) sowie Hunden (Beagle) aus Zwingerhaltung (n=40) 
genutzt wurde. Hierfür kam ein Festphasen IgE assay unter Verwendung einer „Grid-blot“-
Apparatur zur Anwendung. Die Reaktionen wurden semiquantitativ in aufsteigender 
Reihenfolge (0,1,2,3) hinsichtlich ihrer IgE Konzentration im Serum ausgewertet. Die 
Identifizierung IgE-bindender Proteine in HD Extrakten erfolgte mittels Western Blot, unter 
Zuhilfenahme von Sera mit positiven Reaktionen gegen HD (Grad 1 oder Grad 2). 
Ergebnisse – für neun der getesteten Allergene wurden zwischen den vier Gruppen statistisch 
signifikante Unterschiede nachgewiesen. Allerdings zeigten diese keine spezifische 
Verteilung. Im Allgemeinen war die Sensibilisierungsrate gegenüber den „Indoor“ Allergenen 
höher als gegenüber „Outdoor“ Allergenen. Geringe Serum-Konzentrationen an HD-
spezifischem IgE (Grad 1) war in allen Gruppen ein häufiger Befund. Grad 2 Reaktionen gab 
es eher selten, starke Grad 3 Reaktionen wurden nicht nachgewiesen. Sechs Seren von der 
Gruppe der potentiell atopischen Tiere zeigten IgE-Reaktivität mit einem Protein, dessen 
Molekulargewicht bei 11 kDa lag. Dieses Protein wurde in der N-terminalen 
Mikrosequenzierung als humanes Cystatin A identifiziert. Aus den anderen drei Gruppen 
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ausgewählte Kontrollseren zeigten mit diesem Protein keine Reaktion. 
Schlussfolgerungen – Semiquantitativ bestimmte hohe allergenspezifische IgE-Spiegel im 
Serum scheinen nicht mit einer klinischen Hypersensitivität korreliert zu sein und könnten 
lediglich den Kontakt mit der entsprechenden Allergenquelle reflektieren. Im Allgemeinen 
war die Sensibilisierungsrate gegen HD in der in dieser Studie untersuchten Hundepopulation 
gering. Bei Hunden mit erhöhten HD-spezifischen IgE Spiegeln konnte z.T. eine spezifische 
IgE-Reaktivität mit humanem Cystatin A nachgewiesen werden. Das humane Cystatin A 
scheint somit als Auslöser der HD-vermittelten Atopie beim Hund eine Rolle zu spielen. 
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